| 3004 | Pharmaceutical products: Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: |
Trending Over Time: All Countries (USD)
Loading chart... (having trouble? make sure you have the Adobe Flash Player installed)
$1,561,762,032.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2009-01 $1,899,466,851.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2009-02 $2,170,178,427.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2009-03 $1,839,945,588.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2009-04 $2,244,941,020.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2009-05 $2,231,655,843.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2009-06 $1,668,883,132.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2009-07 $1,896,188,696.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2009-08 $1,754,228,355.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2009-09 $1,899,521,285.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2009-10 $1,559,277,760.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2009-11 $1,767,730,645.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2009-12 $1,925,113,477.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2010-01 $1,880,624,281.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2010-02 $2,012,710,826.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2010-03 $1,753,941,363.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2010-04 $1,752,021,793.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2010-05 $1,964,774,852.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2010-06 $1,908,559,604.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2010-07 $1,789,825,998.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2010-08 $2,014,712,236.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2010-09 $2,029,599,475.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2010-10 $2,422,172,261.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2010-11 $1,679,073,801.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2010-12 $1,751,043,788.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2011-01 $1,818,527,557.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2011-02 $2,241,648,134.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2011-03 $2,177,899,562.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2011-04 $2,015,086,978.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2011-05 $2,112,145,627.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2011-06 $1,833,316,624.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2011-07 $2,091,509,341.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2011-08 $2,174,035,904.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2011-09 $2,020,374,860.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2011-10 $2,369,013,215.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2011-11 $1,685,377,038.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2011-12 $1,955,192,010.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2012-01 $1,847,787,559.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2012-02 $2,186,812,405.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2012-03 $2,056,538,887.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2012-04 $2,038,092,084.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2012-05 $2,182,380,215.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2012-06 $2,004,510,750.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2012-07 $2,027,993,746.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2012-08 $2,016,787,070.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2012-09 $2,598,329,965.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2012-10 $2,221,257,870.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2012-11 $1,585,263,832.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2012-12 $1,995,247,365.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2013-01 $1,727,669,522.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2013-02 $1,944,760,993.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2013-03 $1,955,577,360.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: exported by the US in 2013-04
Value of Goods Leaving US: Since 2009 (USD)
| Top 10 buyers | |
|---|---|
| Canada | $12,586,376,284 |
| Netherlands | $11,254,155,305 |
| United Kingdom | $10,292,995,206 |
| Japan | $9,471,523,894 |
| Belgium | $7,338,268,583 |
| Subscribers only | $6,686,697,006 |
| Subscribers only | $5,351,581,343 |
| France | $5,013,267,111 |
| Subscribers only | $3,852,722,236 |
| Subscribers only | $3,660,462,462 |
Loading chart... (having trouble? make sure you have the Adobe Flash Player installed)
Canada imported $12,586,376,284.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. Netherlands imported $11,254,155,305.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. United Kingdom imported $10,292,995,206.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. Japan imported $9,471,523,894.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. Belgium imported $7,338,268,583.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $6,686,697,006.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $5,351,581,343.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. France imported $5,013,267,111.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $3,852,722,236.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $3,660,462,462.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $3,574,513,064.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $3,531,578,292.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. Australia imported $3,136,509,259.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $3,056,995,639.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $1,774,284,249.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $1,676,179,499.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $1,001,590,273.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $890,296,129.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $705,143,541.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $562,795,439.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. Colombia imported $543,173,090.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $484,999,686.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $431,138,552.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $366,116,586.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $349,905,847.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $324,774,518.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $317,038,670.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $278,555,991.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $258,983,154.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $253,061,572.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $242,698,580.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $221,272,897.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $207,822,603.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. Russia imported $144,798,017.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $141,633,572.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $126,522,909.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $125,082,969.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $121,489,215.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $105,677,415.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $101,860,180.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $93,096,091.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $91,411,686.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $89,883,009.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $85,510,821.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $84,072,151.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $80,933,630.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $75,939,975.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $72,585,781.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $64,318,845.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $59,316,860.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $52,736,860.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $51,657,509.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $50,339,909.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $47,775,029.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. Guatemala imported $39,149,912.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $37,159,977.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $32,564,433.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $32,418,184.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $30,792,942.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $30,441,314.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $24,637,861.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $24,358,621.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $21,572,058.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $19,521,277.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $19,513,676.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $19,498,899.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $19,240,358.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $18,225,881.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $17,346,029.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $14,763,503.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $12,857,903.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $12,202,395.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $11,409,668.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $10,231,807.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $10,215,830.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $10,037,527.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $9,688,167.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $9,466,783.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $8,763,701.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $8,708,917.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $8,360,866.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $8,241,034.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $7,576,354.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $7,360,589.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $7,005,059.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $6,581,135.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $6,546,645.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $6,447,474.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. Botswana imported $6,107,054.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $6,011,575.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $4,976,502.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $4,961,124.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $4,879,991.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $4,763,333.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $4,231,461.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $3,969,156.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $3,887,978.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $3,707,443.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $3,691,656.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $3,684,100.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $3,610,668.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $3,517,264.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $3,173,503.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $3,148,522.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $3,063,963.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $3,063,505.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $2,803,222.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $2,688,286.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $2,589,209.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $2,510,274.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $2,443,927.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $2,321,255.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $2,261,339.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $2,253,379.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $2,158,520.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $2,022,827.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $1,971,696.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $1,749,871.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $1,316,653.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $1,303,285.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $1,275,228.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $1,271,872.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $1,138,113.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $1,134,779.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $1,116,917.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $1,085,021.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $1,074,395.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $1,056,378.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $999,406.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $997,463.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $959,389.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $954,618.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $949,176.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $934,752.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $930,901.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $878,786.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $763,362.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $726,011.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $722,356.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $684,825.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $677,402.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $644,604.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $627,517.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. Gibraltar imported $594,144.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $551,673.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $515,352.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $512,866.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $488,320.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $410,395.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $313,274.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $295,393.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $268,698.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $257,650.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $234,688.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $231,435.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $216,388.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $191,216.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $189,379.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $189,054.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $176,184.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $170,149.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $158,019.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $155,553.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $151,550.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $100,805.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $96,200.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $95,465.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $82,633.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $81,746.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $76,823.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $62,960.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $60,988.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $57,647.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $53,588.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $49,857.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $48,732.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $47,156.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $42,020.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $36,585.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $35,271.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $34,121.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $33,415.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $27,782.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $26,503.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $20,000.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $19,988.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $19,371.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $19,200.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $18,768.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $18,538.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $11,655.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $10,692.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $10,010.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $9,577.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $9,331.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $9,222.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $5,395.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $4,009.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $3,865.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $3,746.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US. A country, available to Panjiva subscribers, imported $3,234.00 of HTS Code 3004 — pharmaceutical products: medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: from the US.
Change in Market Share
Largest Change
| Subscribers only | 2.7% |
| Subscribers only | 1.7% |
| Subscribers only | 0.9% |
| Subscribers only | 0.8% |
| Subscribers only | 0.5% |
| Subscribers only | 0.4% |
| Subscribers only | 0.3% |
| Mexico | 0.3% |
| Netherlands | 0.3% |
| Argentina | 0.2% |
| Subscribers only | -3.2% |
| Subscribers only | -2.6% |
| Subscribers only | -1.9% |
| Subscribers only | -0.3% |
| Subscribers only | -0.2% |
| Subscribers only | -0.2% |
| Subscribers only | -0.2% |
| Panama | -0.2% |
| Germany | -0.2% |
| Sweden | -0.1% |
Loading chart... (having trouble? make sure you have the Adobe Flash Player installed)
A country, available to Panjiva subscribers, increased in shipments of HTS Code 3004 — - to the US by 2.721%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 3004 — - to the US by 1.722%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 3004 — - to the US by 0.888%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 3004 — - to the US by 0.758%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 3004 — - to the US by 0.542%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 3004 — - to the US by 0.381%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 3004 — - to the US by 0.329%.
Mexico increased in shipments of HTS Code 3004 — - to the US by 0.310%.
Netherlands increased in shipments of HTS Code 3004 — - to the US by 0.289%.
Argentina increased in shipments of HTS Code 3004 — - to the US by 0.219%.
Sweden decreased in shipments of HTS Code 3004 — - to the US by -0.112%.
Germany decreased in shipments of HTS Code 3004 — - to the US by -0.182%.
Panama decreased in shipments of HTS Code 3004 — - to the US by -0.196%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3004 — - to the US by -0.211%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3004 — - to the US by -0.235%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3004 — - to the US by -0.238%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3004 — - to the US by -0.291%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3004 — - to the US by -1.936%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3004 — - to the US by -2.558%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3004 — - to the US by -3.228%.
Top Global Buyers: $100,000 imported — Showing countries that have shipped 3004
| 2009 | 2010 | 2011 | 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| * | Country | Share | Trend | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All |
100%
|
15,618 | 18,995 | 21,702 | 18,399 | 22,449 | 22,317 | 16,689 | 18,962 | 17,542 | 18,995 | 15,593 | 17,677 | 19,251 | 18,806 | 20,127 | 17,539 | 17,520 | 19,648 | 19,086 | 17,898 | 20,147 | 20,296 | 24,222 | 16,791 | 17,510 | 18,185 | 22,416 | 21,779 | 20,151 | 21,121 | 18,333 | 20,915 | 21,740 | 20,204 | 23,690 | 16,854 | 19,552 | 18,478 | 21,868 | 20,565 | 20,381 | 21,824 | 20,045 | 20,280 | 20,168 | 25,983 | 22,213 | 15,853 | 19,952 | 17,277 | 19,448 | 19,556 | ||||
| 1. | Canada |
12%
|
1,513 | 1,564 | 2,110 | 2,238 | 1,859 | 2,310 | 1,977 | 1,904 | 2,547 | 2,398 | 2,407 | 2,499 | 2,005 | 2,272 | 2,373 | 2,339 | 2,282 | 2,308 | 2,884 | 1,879 | 2,397 | 2,995 | 3,082 | 2,520 | 2,482 | 2,612 | 3,272 | 3,003 | 3,022 | 2,749 | 2,559 | 3,071 | 2,801 | 2,833 | 2,904 | 3,214 | 2,503 | 2,651 | 3,217 | 2,348 | 2,142 | 2,294 | 2,330 | 2,281 | 1,772 | 2,715 | 2,366 | 1,882 | 2,107 | 1,894 | 2,292 | 1,886 | |||
| 2. | Netherlands |
11%
|
2,030 | 3,748 | 2,888 | 4,972 | 4,336 | 4,129 | 2,745 | 2,256 | 1,570 | 2,316 | 1,925 | 2,133 | 3,206 | 2,322 | 1,694 | 1,903 | 1,795 | 3,592 | 2,295 | 1,656 | 1,608 | 3,160 | 1,531 | 2,130 | 2,570 | 1,723 | 2,833 | 1,530 | 1,725 | 2,731 | 1,803 | 1,715 | 2,564 | 1,842 | 1,673 | 966 | 1,573 | 1,467 | 1,185 | 1,397 | 1,299 | 1,773 | 1,330 | 2,893 | 2,407 | 2,036 | 1,961 | 1,663 | 1,960 | 1,372 | 1,384 | 1,223 | |||
| 3. | United Kingdom |
10%
|
2,279 | 1,671 | 2,118 | 1,738 | 1,597 | 1,809 | 1,838 | 2,446 | 1,527 | 2,369 | 1,816 | 1,112 | 1,815 | 1,932 | 2,887 | 1,644 | 1,674 | 2,654 | 2,368 | 2,678 | 1,779 | 1,522 | 2,540 | 1,903 | 1,820 | 2,458 | 2,569 | 2,486 | 1,631 | 1,602 | 1,922 | 2,466 | 1,971 | 1,903 | 1,492 | 707 | 2,271 | 1,695 | 2,571 | 1,810 | 1,965 | 2,427 | 2,459 | 1,786 | 2,300 | 2,401 | 1,950 | 1,188 | 2,111 | 1,930 | 1,863 | 1,459 | |||
| 4. | Japan |
9%
|
1,203 | 1,169 | 1,013 | 714 | 1,551 | 1,397 | 1,082 | 1,406 | 1,135 | 1,221 | 981 | 3,410 | 2,298 | 2,826 | 1,394 | 1,128 | 1,474 | 1,379 | 1,649 | 1,772 | 1,924 | 1,871 | 2,571 | 1,406 | 1,479 | 1,745 | 1,752 | 1,255 | 2,005 | 1,501 | 1,306 | 1,614 | 1,973 | 1,798 | 6,484 | 1,236 | 1,678 | 1,951 | 1,535 | 1,737 | 2,164 | 1,925 | 2,440 | 2,269 | 2,580 | 2,544 | 2,630 | 1,651 | 2,134 | 1,847 | 1,861 | 1,647 | |||
| 5. | Belgium |
7%
|
1,108 | 1,171 | 1,577 | 1,039 | 1,445 | 2,009 | 1,050 | 1,492 | 1,461 | 1,703 | 1,107 | 1,293 | 1,716 | 956 | 1,181 | 950 | 878 | 1,035 | 758 | 945 | 965 | 1,282 | 925 | 1,142 | 865 | 1,166 | 1,246 | 1,671 | 1,478 | 1,768 | 1,261 | 1,333 | 1,241 | 1,860 | 1,558 | 1,117 | 1,181 | 1,391 | 1,770 | 1,592 | 1,873 | 1,460 | 1,382 | 1,884 | 1,348 | 1,852 | 3,792 | 1,572 | 537 | 1,642 | 1,891 | 2,465 | |||
| 6. | Subscribers only |
7%
|
1,161 | 3,204 | 3,344 | 900 | 1,967 | 1,669 | 999 | 1,117 | 1,654 | 1,504 | 1,205 | 1,061 | 1,203 | 629 | 1,645 | 2,260 | 1,202 | 723 | 1,509 | 868 | 1,352 | 1,480 | 1,114 | 1,338 | 1,067 | 1,041 | 1,414 | 1,082 | 918 | 1,219 | 1,112 | 1,301 | 1,323 | 1,151 | 1,161 | 1,007 | 1,321 | 907 | 1,019 | 1,059 | 881 | 1,621 | 1,252 | 857 | 1,376 | 1,505 | 966 | 618 | 1,383 | 767 | 949 | 1,482 | |||
| 7. | Subscribers only |
5%
|
1,042 | 875 | 727 | 1,064 | 3,007 | 900 | 1,086 | 3,043 | 821 | 999 | 716 | 565 | 1,177 | 1,022 | 1,014 | 1,291 | 2,047 | 1,144 | 1,077 | 969 | 786 | 927 | 747 | 615 | 1,089 | 864 | 1,629 | 2,315 | 1,354 | 1,302 | 919 | 2,458 | 849 | 858 | 882 | 1,347 | 916 | 750 | 753 | 711 | 656 | 541 | 704 | 576 | 317 | 1,276 | 498 | 401 | 545 | 480 | 467 | 399 | |||
| 8. | France |
5%
|
809 | 837 | 999 | 1,098 | 950 | 951 | 864 | 541 | 1,038 | 949 | 590 | 549 | 533 | 761 | 940 | 526 | 559 | 698 | 663 | 1,074 | 2,399 | 1,208 | 835 | 688 | 578 | 705 | 691 | 901 | 758 | 842 | 1,071 | 556 | 906 | 544 | 578 | 570 | 557 | 1,185 | 1,249 | 988 | 1,673 | 1,685 | 1,351 | 952 | 1,283 | 2,473 | 1,708 | 678 | 1,537 | 859 | 934 | 1,260 | |||
| 9. | Subscribers only |
4%
|
688 | 594 | 793 | 675 | 582 | 608 | 674 | 651 | 774 | 807 | 509 | 533 | 821 | 994 | 1,107 | 816 | 615 | 957 | 792 | 707 | 664 | 837 | 737 | 766 | 591 | 526 | 632 | 922 | 775 | 806 | 729 | 714 | 652 | 971 | 670 | 719 | 619 | 680 | 911 | 1,063 | 890 | 1,126 | 991 | 658 | 586 | 584 | 549 | 324 | 722 | 813 | 771 | 833 | |||
| 10. | Subscribers only |
4%
|
576 | 551 | 704 | 368 | 676 | 779 | 351 | 374 | 544 | 492 | 691 | 400 | 671 | 537 | 670 | 594 | 484 | 693 | 448 | 704 | 1,045 | 374 | 1,743 | 636 | 437 | 1,160 | 1,004 | 1,289 | 1,086 | 1,167 | 528 | 919 | 728 | 946 | 1,041 | 992 | 499 | 937 | 1,327 | 997 | 604 | 777 | 287 | 703 | 244 | 978 | 394 | 264 | 534 | 260 | 664 | 732 | |||
| 11. | Subscribers only |
3%
|
284 | 160 | 295 | 220 | 343 | 362 | 472 | 405 | 850 | 396 | 503 | 515 | 608 | 706 | 658 | 637 | 713 | 531 | 625 | 677 | 429 | 508 | 956 | 334 | 657 | 781 | 708 | 792 | 758 | 1,029 | 679 | 675 | 902 | 657 | 843 | 739 | 1,814 | 456 | 694 | 1,429 | 1,184 | 688 | 705 | 700 | 826 | 917 | 761 | 675 | 1,197 | 815 | 823 | 655 | |||
| 12. | Subscribers only |
3%
|
398 | 509 | 538 | 515 | 640 | 599 | 515 | 539 | 465 | 437 | 459 | 375 | 357 | 622 | 844 | 491 | 638 | 514 | 682 | 484 | 969 | 557 | 1,267 | 521 | 561 | 604 | 641 | 741 | 902 | 567 | 605 | 690 | 909 | 801 | 615 | 636 | 860 | 890 | 716 | 859 | 965 | 1,288 | 723 | 870 | 986 | 1,075 | 704 | 601 | 563 | 833 | 507 | 669 | |||
| 13. | Australia |
3%
|
610 | 384 | 2,194 | 413 | 1,061 | 2,160 | 545 | 643 | 445 | 735 | 298 | 657 | 750 | 704 | 773 | 603 | 669 | 736 | 846 | 506 | 814 | 545 | 716 | 347 | 637 | 314 | 405 | 591 | 487 | 448 | 380 | 497 | 529 | 404 | 491 | 402 | 423 | 553 | 899 | 416 | 389 | 367 | 463 | 574 | 549 | 409 | 342 | 586 | 490 | 295 | 515 | 357 | |||
| 14. | Subscribers only |
3%
|
264 | 536 | 456 | 443 | 468 | 388 | 506 | 393 | 378 | 319 | 557 | 471 | 319 | 516 | 620 | 588 | 488 | 680 | 347 | 614 | 697 | 416 | 1,210 | 305 | 576 | 213 | 906 | 844 | 432 | 647 | 753 | 458 | 1,066 | 685 | 504 | 400 | 585 | 433 | 946 | 724 | 520 | 576 | 409 | 337 | 811 | 1,772 | 724 | 619 | 574 | 476 | 820 | 780 | |||
| 15. | Subscribers only |
2%
|
140 | 166 | 198 | 147 | 162 | 157 | 342 | 147 | 190 | 210 | 269 | 368 | 89 | 237 | 335 | 243 | 232 | 331 | 191 | 128 | 224 | 183 | 315 | 368 | 222 | 299 | 249 | 368 | 295 | 380 | 375 | 387 | 495 | 197 | 351 | 298 | 625 | 255 | 359 | 524 | 467 | 520 | 669 | 394 | 470 | 369 | 661 | 598 | 662 | 491 | 708 | 683 | |||
| 16. | Subscribers only |
2%
|
81 | 95 | 153 | 102 | 162 | 122 | 114 | 51 | 155 | 134 | 107 | 127 | 135 | 121 | 189 | 134 | 147 | 165 | 165 | 225 | 171 | 228 | 454 | 378 | 300 | 317 | 305 | 342 | 387 | 436 | 496 | 249 | 646 | 477 | 522 | 563 | 169 | 510 | 219 | 465 | 335 | 565 | 483 | 474 | 448 | 613 | 444 | 586 | 664 | 481 | 817 | 535 | |||
| 17. | Subscribers only |
1%
|
161 | 176 | 149 | 119 | 108 | 122 | 122 | 62 | 82 | 131 | 68 | 86 | 213 | 160 | 195 | 96 | 180 | 168 | 116 | 183 | 192 | 559 | 269 | 78 | 238 | 128 | 250 | 124 | 194 | 190 | 155 | 141 | 234 | 165 | 199 | 140 | 311 | 155 | 328 | 266 | 252 | 278 | 229 | 241 | 141 | 357 | 176 | 200 | 214 | 210 | 267 | 440 | |||
| 18. | Subscribers only |
1%
|
115 | 112 | 118 | 125 | 86 | 114 | 198 | 110 | 69 | 182 | 119 | 92 | 88 | 128 | 169 | 94 | 106 | 106 | 150 | 156 | 126 | 376 | 842 | 109 | 110 | 163 | 179 | 158 | 131 | 251 | 95 | 136 | 148 | 263 | 181 | 141 | 93 | 120 | 198 | 244 | 286 | 76 | 236 | 130 | 215 | 180 | 165 | 189 | 249 | 253 | 113 | 313 | |||
| 19. | Subscribers only |
1%
|
59 | 200 | 65 | 313 | 111 | 142 | 100 | 149 | 88 | 84 | 94 | 185 | 62 | 108 | 80 | 56 | 107 | 117 | 324 | 330 | 117 | 106 | 202 | 102 | 126 | 92 | 195 | 78 | 127 | 107 | 131 | 120 | 157 | 145 | 94 | 249 | 67 | 154 | 134 | 164 | 237 | 82 | 125 | 139 | 107 | 138 | 96 | 154 | 124 | 72 | 175 | 156 | |||
| 20. | Subscribers only |
1%
|
44 | 56 | 118 | 46 | 45 | 76 | 65 | 54 | 68 | 91 | 61 | 55 | 34 | 124 | 101 | 39 | 107 | 78 | 86 | 167 | 213 | 75 | 1,102 | 34 | 39 | 56 | 90 | 118 | 77 | 160 | 63 | 98 | 157 | 162 | 86 | 38 | 58 | 109 | 58 | 233 | 73 | 150 | 152 | 70 | 64 | 146 | 92 | 31 | 114 | 71 | 71 | 51 | |||
| 21. | Colombia |
1%
|
84 | 91 | 120 | 75 | 81 | 181 | 92 | 178 | 92 | 88 | 56 | 93 | 117 | 155 | 88 | 61 | 77 | 54 | 77 | 79 | 74 | 65 | 82 | 84 | 72 | 97 | 71 | 85 | 62 | 121 | 62 | 77 | 109 | 261 | 84 | 55 | 88 | 96 | 105 | 99 | 94 | 138 | 126 | 118 | 114 | 227 | 146 | 137 | 164 | 97 | 156 | 124 | |||
| 22. | Subscribers only |
<1%
|
96 | 97 | 68 | 70 | 97 | 84 | 132 | 41 | 56 | 94 | 57 | 35 | 113 | 132 | 65 | 77 | 84 | 94 | 51 | 86 | 90 | 88 | 66 | 63 | 71 | 110 | 96 | 81 | 85 | 65 | 76 | 82 | 74 | 65 | 115 | 90 | 197 | 84 | 105 | 127 | 107 | 122 | 81 | 82 | 105 | 109 | 144 | 79 | 204 | 118 | 98 | 139 | |||
| 23. | Subscribers only |
<1%
|
137 | 182 | 24 | 173 | 30 | 52 | 13 | 128 | 487 | 195 | 37 | 64 | 20 | 52 | 18 | 84 | 28 | 9.45 | 12 | 38 | 36 | 26 | 41 | 37 | 42 | 65 | 94 | 40 | 111 | 108 | 65 | 100 | 144 | 151 | 122 | 105 | 119 | 73 | 56 | 56 | 85 | 107 | 66 | 135 | 72 | 60 | 60 | 94 | 47 | 27 | 78 | 106 | |||
| 24. | Subscribers only |
<1%
|
30 | 63 | 39 | 24 | 21 | 228 | 29 | 24 | 133 | 65 | 28 | 60 | 38 | 92 | 204 | 40 | 62 | 80 | 97 | 63 | 110 | 39 | 30 | 77 | 36 | 56 | 105 | 75 | 91 | 97 | 144 | 124 | 59 | 66 | 95 | 66 | 122 | 100 | 46 | 103 | 40 | 55 | 47 | 28 | 53 | 91 | 15 | 51 | 70 | 58 | 46 | 46 | |||
| 25. | Subscribers only |
<1%
|
40 | 55 | 43 | 68 | 37 | 60 | 52 | 38 | 68 | 73 | 64 | 73 | 47 | 45 | 69 | 70 | 44 | 53 | 50 | 44 | 35 | 50 | 49 | 87 | 50 | 94 | 57 | 61 | 68 | 63 | 67 | 40 | 60 | 86 | 52 | 54 | 42 | 62 | 73 | 75 | 110 | 118 | 87 | 71 | 104 | 83 | 52 | 114 | 61 | 114 | 181 | 87 | |||
| 26. | Subscribers only |
<1%
|
11 | 27 | 52 | 9.61 | 56 | 36 | 28 | 36 | 49 | 40 | 49 | 156 | 14 | 16 | 74 | 27 | 46 | 34 | 54 | 53 | 72 | 40 | 51 | 77 | 44 | 30 | 121 | 67 | 144 | 86 | 76 | 135 | 122 | 62 | 93 | 86 | 75 | 69 | 182 | 50 | 136 | 74 | 92 | 65 | 58 | 46 | 54 | 45 | 17 | 28 | 31 | 55 | |||
| 27. | Subscribers only |
<1%
|
19 | 10 | 23 | 6.34 | 14 | 17 | 21 | 61 | 48 | 60 | 77 | 41 | 50 | 74 | 57 | 42 | 57 | 82 | 43 | 78 | 57 | 46 | 72 | 48 | 23 | 33 | 37 | 49 | 262 | 29 | 210 | 47 | 89 | 58 | 71 | 70 | 63 | 74 | 101 | 175 | 75 | 62 | 96 | 72 | 51 | 35 | 14 | 43 | 53 | 43 | 61 | 71 | |||
| 28. | Subscribers only |
<1%
|
53 | 57 | 74 | 45 | 50 | 107 | 45 | 49 | 51 | 161 | 53 | 46 | 48 | 31 | 51 | 30 | 52 | 37 | 35 | 49 | 59 | 30 | 38 | 47 | 54 | 15 | 59 | 37 | 32 | 49 | 32 | 43 | 41 | 54 | 59 | 33 | 57 | 56 | 64 | 64 | 45 | 37 | 65 | 57 | 34 | 72 | 68 | 48 | 48 | 97 | 81 | 85 | |||
| 29. | Subscribers only |
<1%
|
40 | 50 | 34 | 48 | 40 | 40 | 29 | 48 | 41 | 33 | 35 | 35 | 33 | 34 | 33 | 41 | 48 | 29 | 42 | 23 | 36 | 47 | 52 | 51 | 80 | 41 | 57 | 48 | 52 | 29 | 57 | 68 | 44 | 31 | 57 | 28 | 73 | 31 | 90 | 40 | 97 | 104 | 47 | 78 | 46 | 69 | 57 | 59 | 62 | 52 | 90 | 57 | |||
| 30. | Subscribers only |
<1%
|
46 | 18 | 31 | 13 | 41 | 33 | 36 | 25 | 34 | 47 | 34 | 42 | 70 | 31 | 47 | 46 | 35 | 29 | 41 | 48 | 43 | 62 | 52 | 29 | 66 | 47 | 111 | 57 | 61 | 44 | 50 | 45 | 105 | 38 | 21 | 57 | 35 | 37 | 68 | 53 | 68 | 82 | 43 | 55 | 72 | 79 | 44 | 41 | 62 | 55 | 50 | 50 | |||
| 31. | Subscribers only |
<1%
|
24 | 25 | 54 | 46 | 26 | 30 | 34 | 23 | 29 | 37 | 40 | 31 | 29 | 28 | 55 | 24 | 37 | 33 | 27 | 38 | 60 | 36 | 46 | 33 | 56 | 42 | 52 | 52 | 65 | 35 | 48 | 72 | 54 | 48 | 51 | 37 | 70 | 47 | 55 | 57 | 64 | 62 | 82 | 56 | 63 | 57 | 53 | 42 | 78 | 74 | 54 | 53 | |||
| 32. | Subscribers only |
<1%
|
18 | 63 | 60 | 90 | 51 | 40 | 13 | 51 | 20 | 34 | 49 | 24 | 30 | 30 | 56 | 33 | 68 | 33 | 20 | 89 | 57 | 63 | 45 | 23 | 65 | 53 | 49 | 51 | 30 | 53 | 64 | 43 | 44 | 58 | 52 | 11 | 16 | 13 | 31 | 18 | 28 | 30 | 46 | 36 | 32 | 24 | 44 | 100 | 51 | 46 | 30 | 36 | |||
| 33. | Subscribers only |
<1%
|
27 | 25 | 34 | 36 | 80 | 50 | 71 | 25 | 25 | 29 | 25 | 174 | 32 | 24 | 37 | 23 | 45 | 41 | 30 | 25 | 39 | 36 | 27 | 47 | 36 | 26 | 49 | 31 | 46 | 25 | 32 | 27 | 21 | 48 | 60 | 41 | 26 | 30 | 50 | 39 | 36 | 47 | 21 | 42 | 40 | 44 | 38 | 55 | 48 | 36 | 24 | 52 | |||
| 34. | Russia |
<1%
|
7.43 | 6.62 | 13 | 3.92 | 18 | 19 | 20 | 24 | 14 | 14 | 7.19 | 10 | 8.35 | 15 | 16 | 43 | 11 | 19 | 12 | 9.67 | 14 | 13 | 20 | 17 | 19 | 34 | 15 | 14 | 20 | 35 | 19 | 33 | 40 | 35 | 28 | 51 | 25 | 11 | 166 | 15 | 26 | 86 | 29 | 62 | 24 | 48 | 41 | 59 | 28 | 23 | 34 | 73 | |||
| 35. | Subscribers only |
<1%
|
15 | 16 | 19 | 14 | 16 | 56 | 20 | 15 | 18 | 27 | 14 | 22 | 14 | 6.95 | 16 | 29 | 37 | 22 | 17 | 17 | 19 | 38 | 19 | 28 | 18 | 60 | 24 | 24 | 57 | 23 | 18 | 24 | 43 | 47 | 15 | 30 | 24 | 20 | 68 | 19 | 30 | 60 | 33 | 38 | 20 | 33 | 15 | 19 | 32 | 48 | 33 | 24 | |||
| 36. | Subscribers only |
<1%
|
11 | 13 | 15 | 55 | 6.41 | 48 | 22 | 11 | 18 | 12 | 19 | 12 | 19 | 18 | 23 | 21 | 21 | 33 | 13 | 11 | 19 | 18 | 9.53 | 23 | 20 | 24 | 40 | 26 | 41 | 31 | 9.08 | 9.92 | 30 | 24 | 11 | 25 | 15 | 23 | 35 | 47 | 30 | 36 | 7.08 | 43 | 35 | 44 | 39 | 30 | 30 | 17 | 40 | 33 | |||
| 37. | Subscribers only |
<1%
|
23 | 17 | 19 | 16 | 21 | 45 | 34 | 26 | 12 | 28 | 21 | 21 | 19 | 23 | 26 | 24 | 66 | 18 | 27 | 14 | 14 | 35 | 18 | 13 | 22 | 16 | 16 | 19 | 17 | 25 | 19 | 19 | 28 | 19 | 14 | 16 | 16 | 28 | 33 | 16 | 27 | 33 | 19 | 25 | 39 | 42 | 25 | 26 | 29 | 31 | 30 | 25 | |||
| 38. | Subscribers only |
<1%
|
12 | 8.25 | 31 | 18 | 17 | 12 | 12 | 19 | 18 | 10 | 23 | 18 | 16 | 19 | 14 | 18 | 11 | 19 | 12 | 13 | 17 | 16 | 17 | 10 | 13 | 30 | 18 | 23 | 11 | 17 | 22 | 29 | 17 | 35 | 29 | 58 | 32 | 60 | 37 | 28 | 17 | 26 | 31 | 14 | 24 | 22 | 18 | 17 | 116 | 41 | 22 | 25 | |||
| 39. | Subscribers only |
<1%
|
50 | 48 | 55 | 2.78 | 71 | 60 | 8.75 | 62 | 1.89 | 75 | 75 | 1.21 | 117 | 1.91 | 0.44 | 64 | 4.43 | 3.19 | 62 | 64 | 3.04 | 12 | 4.86 | 1.76 | 5.49 | 5.78 | 4.67 | 7.59 | 6.79 | 7.35 | 4.49 | 4.02 | 4.71 | 5.53 | 9.72 | 2.51 | 10 | 6.75 | 8.69 | 11 | 7.45 | 9.95 | 4.25 | 14 | 7.59 | 18 | 3.50 | 4.71 | 2.78 | 5.25 | 14 | 10 | |||
| 40. | Subscribers only |
<1%
|
13 | 8.39 | 7.32 | 7.09 | 14 | 13 | 8.13 | 15 | 11 | 31 | 14 | 22 | 12 | 10 | 17 | 24 | 17 | 18 | 24 | 20 | 17 | 24 | 33 | 20 | 21 | 19 | 8.31 | 26 | 22 | 20 | 23 | 17 | 27 | 21 | 13 | 33 | 21 | 22 | 42 | 15 | 18 | 28 | 12 | 30 | 27 | 20 | 23 | 23 | 22 | 12 | 37 | 12 | |||
| 41. | Subscribers only |
<1%
|
9.90 | 15 | 16 | 12 | 43 | 25 | 7.10 | 12 | 9.63 | 12 | 13 | 5.56 | 6.91 | 17 | 8.52 | 12 | 29 | 20 | 19 | 15 | 12 | 19 | 12 | 7.64 | 18 | 13 | 73 | 9.14 | 17 | 12 | 24 | 15 | 25 | 18 | 17 | 17 | 18 | 19 | 25 | 26 | 11 | 28 | 15 | 23 | 14 | 19 | 16 | 17 | 18 | 16 | 30 | 18 | |||
| 42. | Subscribers only |
<1%
|
1.76 | 4.57 | 2.23 | 2.59 | 1.74 | 31 | 17 | 10 | 31 | 22 | 16 | 24 | 25 | 9.01 | 22 | 23 | 24 | 16 | 22 | 39 | 22 | 14 | 20 | 23 | 12 | 15 | 28 | 13 | 28 | 18 | 16 | 14 | 37 | 20 | 31 | 20 | 18 | 16 | 21 | 19 | 17 | 11 | 5.35 | 7.05 | 13 | 14 | 16 | 6.64 | 9.30 | 22 | 13 | 32 | |||
| 43. | Subscribers only |
<1%
|
4.81 | 2.71 | 4.04 | 4.64 | 2.05 | 2.36 | 4.05 | 10 | 17 | 25 | 85 | 6.28 | 6.15 | 23 | 21 | 14 | 10 | 20 | 21 | 13 | 16 | 32 | 16 | 14 | 19 | 11 | 11 | 15 | 25 | 13 | 7.76 | 21 | 7.18 | 19 | 24 | 21 | 7.59 | 19 | 22 | 11 | 35 | 16 | 27 | 32 | 21 | 11 | 23 | 26 | 14 | 28 | 16 | 22 | |||
| 44. | Subscribers only |
<1%
|
26 | 0 | 19 | 13 | 39 | 0 | 3.95 | 28 | 96 | 0.64 | 0.29 | 8.92 | 1.50 | 9.15 | 1.76 | 10 | 5.33 | 1.12 | 11 | 1.97 | 69 | 17 | 29 | 28 | 32 | 37 | 31 | 33 | 8.09 | 0 | 37 | 0.32 | 2.99 | 11 | 1.11 | 99 | 19 | 4.36 | 10 | 0.80 | 12 | 8.84 | 0 | 20 | 0 | 63 | 3.43 | 0.24 | 0.38 | 0 | 1.25 | 0 | |||
| 45. | Subscribers only |
<1%
|
11 | 25 | 11 | 17 | 57 | 24 | 46 | 58 | 45 | 63 | 32 | 8.86 | 46 | 16 | 27 | 34 | 27 | 39 | 9.72 | 7.90 | 23 | 5.41 | 7.87 | 6.33 | 7.55 | 18 | 3.77 | 2.98 | 4.91 | 5.12 | 8.83 | 5.77 | 7.82 | 6.35 | 5.58 | 11 | 8.19 | 1.57 | 7.11 | 7.98 | 13 | 3.18 | 8.03 | 2.97 | 4.25 | 15 | 3.21 | 3.58 | 2.78 | 15 | 5.64 | 3.86 | |||
| 46. | Subscribers only |
<1%
|
3.24 | 6.94 | 2.00 | 5.12 | 3.08 | 17 | 3.18 | 5.71 | 12 | 9.81 | 20 | 4.64 | 12 | 10 | 9.90 | 18 | 5.44 | 15 | 24 | 5.31 | 5.12 | 12 | 14 | 8.46 | 15 | 17 | 21 | 15 | 16 | 6.71 | 19 | 20 | 16 | 31 | 21 | 22 | 17 | 18 | 19 | 61 | 14 | 10 | 19 | 17 | 23 | 26 | 15 | 20 | 33 | 12 | 33 | 20 | |||
| 47. | Subscribers only |
<1%
|
7.75 | 11 | 12 | 11 | 16 | 9.59 | 7.96 | 4.16 | 16 | 6.80 | 6.39 | 13 | 14 | 9.71 | 21 | 17 | 13 | 7.43 | 13 | 11 | 12 | 8.21 | 16 | 8.27 | 23 | 25 | 14 | 18 | 9.94 | 15 | 6.63 | 13 | 16 | 15 | 3.75 | 8.54 | 18 | 21 | 40 | 28 | 14 | 16 | 12 | 10 | 28 | 18 | 11 | 19 | 35 | 12 | 25 | 16 | |||
| 48. | Subscribers only |
<1%
|
3.06 | 20 | 33 | 12 | 28 | 8.85 | 5.53 | 7.46 | 6.48 | 22 | 10 | 4.88 | 19 | 27 | 7.91 | 14 | 17 | 22 | 11 | 7.90 | 5.70 | 6.10 | 2.77 | 3.88 | 6.62 | 18 | 7.48 | 3.00 | 9.46 | 20 | 8.22 | 8.73 | 14 | 11 | 9.06 | 18 | 8.15 | 19 | 11 | 38 | 14 | 11 | 8.87 | 23 | 6.90 | 45 | 5.87 | 36 | 12 | 8.64 | 9.84 | 27 | |||
| 49. | Subscribers only |
<1%
|
37 | 53 | 14 | 31 | 38 | 20 | 1.07 | 2.49 | 3.63 | 10 | 0.26 | 2.77 | 0.42 | 1.51 | 6.36 | 0.43 | 0.74 | 4.98 | 3.48 | 0.29 | 11 | 21 | 0.80 | 6.42 | 8.28 | 21 | 19 | 23 | 31 | 2.10 | 16 | 1.38 | 21 | 15 | 22 | 18 | 9.53 | 4.62 | 0 | 31 | 25 | 9.93 | 15 | 30 | 0 | 12 | 0.90 | 3.86 | 0.07 | 12 | 15 | 4.93 | |||
| 50. | Subscribers only |
<1%
|
11 | 3.55 | 11 | 11 | 8.50 | 13 | 5.38 | 10 | 2.80 | 9.70 | 6.91 | 4.90 | 8.49 | 8.64 | 13 | 11 | 13 | 12 | 7.01 | 8.44 | 15 | 9.33 | 14 | 9.37 | 7.88 | 11 | 15 | 12 | 7.31 | 9.25 | 20 | 29 | 13 | 17 | 7.32 | 15 | 11 | 16 | 6.33 | 29 | 19 | 11 | 13 | 9.79 | 13 | 9.02 | 12 | 6.50 | 9.72 | 13 | 14 | 12 | |||
| 51. | Subscribers only |
<1%
|
17 | 21 | 14 | 29 | 25 | 24 | 76 | 14 | 44 | 16 | 2.62 | 4.75 | 4.29 | 7.26 | 7.18 | 8.57 | 5.45 | 14 | 8.55 | 7.25 | 5.08 | 11 | 12 | 6.92 | 7.26 | 11 | 17 | 5.04 | 5.79 | 2.68 | 3.41 | 5.12 | 3.66 | 3.87 | 4.79 | 5.48 | 2.50 | 1.08 | 4.59 | 1.73 | 5.09 | 3.24 | 4.58 | 7.00 | 3.93 | 3.29 | 1.67 | 6.71 | 4.87 | 4.95 | 9.03 | 4.32 | |||
| 52. | Subscribers only |
<1%
|
5.89 | 5.36 | 2.00 | 5.94 | 5.93 | 6.86 | 2.62 | 3.96 | 1.61 | 1.84 | 7.55 | 1.62 | 15 | 5.35 | 2.34 | 7.39 | 4.61 | 4.26 | 12 | 5.23 | 12 | 12 | 10 | 7.12 | 4.85 | 15 | 10 | 6.80 | 18 | 4.81 | 11 | 11 | 20 | 18 | 12 | 6.80 | 8.17 | 15 | 13 | 15 | 14 | 12 | 15 | 19 | 12 | 23 | 12 | 9.26 | 12 | 12 | 23 | 16 | |||
| 53. | Subscribers only |
<1%
|
8.39 | 8.00 | 15 | 8.03 | 13 | 8.61 | 12 | 9.90 | 11 | 7.52 | 13 | 17 | 7.23 | 16 | 9.83 | 8.27 | 7.40 | 7.06 | 6.69 | 5.30 | 13 | 10 | 14 | 13 | 4.59 | 7.04 | 9.64 | 7.98 | 9.02 | 11 | 6.88 | 10 | 10 | 10 | 13 | 11 | 3.97 | 10 | 11 | 7.95 | 8.61 | 9.84 | 4.65 | 4.94 | 5.78 | 13 | 13 | 9.71 | 6.83 | 8.68 | 16 | 8.27 | |||
| 54. | Subscribers only |
<1%
|
6.25 | 5.46 | 4.72 | 5.16 | 6.41 | 6.45 | 5.67 | 5.56 | 8.46 | 5.08 | 5.94 | 4.11 | 3.56 | 13 | 3.61 | 7.63 | 3.42 | 3.83 | 49 | 53 | 67 | 6.04 | 7.43 | 3.49 | 7.34 | 4.13 | 5.48 | 4.32 | 4.80 | 8.52 | 5.99 | 5.92 | 2.39 | 8.83 | 6.97 | 5.70 | 4.96 | 4.15 | 6.38 | 7.72 | 7.75 | 8.04 | 7.63 | 16 | 9.72 | 12 | 7.63 | 4.67 | 3.22 | 6.85 | 4.61 | 6.20 | |||
| 55. | Guatemala |
<1%
|
12 | 11 | 6.48 | 4.05 | 6.74 | 6.29 | 3.37 | 8.40 | 4.34 | 5.34 | 6.75 | 4.51 | 5.22 | 10 | 5.65 | 5.36 | 9.88 | 2.87 | 42 | 34 | 6.50 | 11 | 2.71 | 5.02 | 5.04 | 6.85 | 6.34 | 5.79 | 5.06 | 6.12 | 3.93 | 15 | 6.46 | 1.63 | 6.65 | 5.56 | 6.86 | 6.87 | 6.17 | 4.99 | 7.35 | 2.33 | 10 | 4.37 | 2.22 | 6.22 | 3.00 | 14 | 8.72 | 5.87 | 3.30 | 4.84 | |||
| 56. | Subscribers only |
<1%
|
4.93 | 10 | 28 | 10 | 17 | 9.19 | 11 | 14 | 8.00 | 7.08 | 8.47 | 2.95 | 5.06 | 11 | 12 | 6.13 | 1.85 | 3.14 | 11 | 18 | 7.95 | 2.63 | 5.42 | 4.65 | 4.39 | 2.16 | 4.65 | 6.54 | 4.74 | 9.93 | 6.80 | 3.80 | 11 | 3.20 | 4.00 | 1.71 | 4.82 | 1.45 | 2.37 | 11 | 10 | 4.26 | 1.61 | 2.09 | 1.92 | 2.77 | 7.14 | 1.75 | 1.05 | 3.58 | 16 | 16 | |||
| 57. | Subscribers only |
<1%
|
5.72 | 7.69 | 5.96 | 9.17 | 8.65 | 5.02 | 5.51 | 5.51 | 7.57 | 6.59 | 7.41 | 5.77 | 5.26 | 8.26 | 4.22 | 9.06 | 3.60 | 7.13 | 6.93 | 9.29 | 5.73 | 6.20 | 7.71 | 6.10 | 5.95 | 4.10 | 10 | 9.76 | 6.03 | 7.76 | 5.56 | 6.85 | 6.10 | 7.40 | 3.70 | 9.15 | 3.57 | 5.12 | 5.35 | 3.41 | 5.55 | 4.51 | 5.98 | 7.43 | 7.31 | 4.70 | 5.94 | 6.62 | 3.99 | 5.74 | 3.39 | 4.58 | |||
| 58. | Subscribers only |
<1%
|
7.29 | 3.33 | 5.94 | 3.35 | 6.72 | 2.39 | 6.03 | 1.01 | 7.50 | 8.27 | 3.02 | 1.22 | 4.89 | 2.95 | 8.26 | 3.28 | 8.37 | 8.59 | 4.27 | 1.50 | 3.81 | 7.77 | 4.87 | 2.50 | 1.90 | 4.02 | 2.80 | 7.54 | 2.16 | 5.14 | 4.42 | 5.18 | 8.29 | 14 | 7.33 | 4.37 | 18 | 5.40 | 5.20 | 4.42 | 13 | 13 | 7.75 | 3.58 | 19 | 8.57 | 8.87 | 6.83 | 7.14 | 7.58 | 8.14 | 3.67 | |||
| 59. | Subscribers only |
<1%
|
12 | 24 | 24 | 3.51 | 4.61 | 8.12 | 5.10 | 2.92 | 4.67 | 5.39 | 11 | 3.24 | 1.64 | 4.32 | 3.03 | 4.69 | 3.92 | 7.60 | 5.12 | 5.51 | 4.68 | 5.43 | 4.06 | 3.44 | 3.51 | 6.56 | 1.89 | 4.78 | 2.29 | 4.93 | 8.50 | 1.86 | 5.62 | 6.25 | 3.60 | 4.64 | 4.05 | 4.81 | 5.50 | 5.99 | 7.58 | 2.94 | 3.61 | 5.84 | 5.37 | 5.41 | 4.87 | 6.03 | 6.92 | 5.38 | 3.74 | 15 | |||
| 60. | Subscribers only |
<1%
|
4.73 | 4.15 | 3.04 | 1.33 | 6.24 | 9.38 | 6.59 | 6.67 | 4.22 | 13 | 1.80 | 6.71 | 1.21 | 4.61 | 3.33 | 0.60 | 3.61 | 0.29 | 7.23 | 2.27 | 2.98 | 1.08 | 13 | 4.58 | 1.95 | 1.86 | 9.28 | 4.59 | 19 | 2.72 | 0.45 | 0.24 | 22 | 2.08 | 4.56 | 6.12 | 14 | 0.85 | 5.68 | 1.16 | 13 | 8.57 | 1.65 | 11 | 12 | 6.92 | 5.49 | 8.23 | 5.04 | 14 | 1.96 | 7.22 | |||
| 61. | Subscribers only |
<1%
|
9.21 | 0.08 | 0.22 | 2.27 | 23 | 0 | 0.21 | 0.36 | 0.21 | 11 | 6.73 | 0.19 | 0.14 | 6.92 | 1.50 | 1.05 | 0 | 0.70 | 2.50 | 0 | 0 | 5.64 | 0.32 | 0.23 | 0.07 | 2.62 | 0 | 0 | 0 | 0 | 0 | 0 | 0.82 | 2.04 | 8.44 | 15 | 6.70 | 0 | 1.70 | 6.37 | 0 | 4.68 | 18 | 20 | 17 | 5.35 | 1.28 | 0.04 | 23 | 8.81 | 14 | 19 | |||
| 62. | Subscribers only |
<1%
|
0.15 | 0 | 0.17 | 0.28 | 0 | 0 | 0.36 | 0.94 | 0 | 1.30 | 1.88 | 6.72 | 1.13 | 5.66 | 7.80 | 5.50 | 1.65 | 6.52 | 5.01 | 0.12 | 1.01 | 0.09 | 0 | 6.82 | 0.57 | 9.13 | 0 | 0.69 | 5.66 | 5.62 | 0 | 6.42 | 0.31 | 5.18 | 0.31 | 8.81 | 6.48 | 6.19 | 8.24 | 7.34 | 13 | 6.15 | 14 | 19 | 27 | 0 | 0.31 | 1.64 | 8.09 | 0.93 | 13 | 17 | |||
| 63. | Subscribers only |
<1%
|
3.73 | 4.20 | 12 | 2.86 | 2.23 | 2.23 | 1.72 | 1.82 | 4.78 | 2.38 | 4.19 | 7.22 | 2.21 | 3.88 | 9.52 | 2.55 | 4.16 | 5.18 | 5.67 | 3.05 | 1.70 | 5.54 | 2.66 | 2.44 | 7.15 | 3.42 | 2.98 | 4.99 | 4.25 | 2.12 | 1.66 | 4.81 | 7.85 | 3.66 | 3.87 | 4.33 | 2.18 | 5.57 | 9.37 | 3.49 | 3.85 | 4.50 | 2.63 | 2.64 | 6.03 | 3.57 | 4.59 | 2.03 | 2.91 | 3.75 | 6.65 | 3.17 | |||
| 64. | Subscribers only |
<1%
|
0.28 | 4.39 | 1.70 | 5.72 | 2.12 | 4.82 | 2.68 | 1.67 | 4.08 | 2.82 | 0.42 | 5.93 | 2.10 | 1.45 | 6.83 | 11 | 2.62 | 1.37 | 2.96 | 4.14 | 7.48 | 6.36 | 1.67 | 3.53 | 1.68 | 7.68 | 4.61 | 2.89 | 5.91 | 1.65 | 3.05 | 4.84 | 0.61 | 4.98 | 4.00 | 4.30 | 4.94 | 2.26 | 5.58 | 4.03 | 6.95 | 3.65 | 0.94 | 2.99 | 3.58 | 4.97 | 3.33 | 2.99 | 2.89 | 3.41 | 4.37 | 4.11 | |||
| 65. | Subscribers only |
<1%
|
11 | 7.55 | 5.28 | 4.06 | 4.83 | 3.69 | 3.59 | 2.64 | 2.82 | 4.40 | 2.74 | 2.14 | 1.79 | 2.87 | 3.03 | 7.75 | 3.20 | 3.82 | 1.81 | 2.95 | 2.71 | 3.68 | 3.32 | 6.85 | 3.39 | 2.59 | 2.72 | 3.08 | 4.17 | 3.17 | 1.85 | 2.27 | 3.79 | 2.55 | 3.48 | 2.49 | 3.38 | 2.94 | 2.90 | 2.28 | 4.67 | 4.66 | 1.94 | 4.49 | 3.21 | 4.95 | 4.06 | 4.28 | 2.84 | 6.03 | 4.53 | 3.86 | |||
| 66. | Subscribers only |
<1%
|
12 | 11 | 10 | 0.43 | 0.38 | 0 | 0.41 | 0.91 | 15 | 22 | 0 | 0.14 | 0.14 | 0 | 0.16 | 0.03 | 0.03 | 0 | 0.60 | 0.97 | 3.37 | 7.25 | 0.18 | 2.80 | 0.27 | 7.16 | 4.29 | 4.18 | 2.94 | 3.37 | 5.44 | 6.29 | 1.61 | 2.62 | 3.22 | 3.47 | 0 | 3.32 | 3.60 | 6.05 | 3.57 | 5.87 | 4.62 | 2.57 | 3.52 | 7.00 | 2.36 | 3.69 | 6.87 | 4.68 | 0.23 | 3.98 | |||
| 67. | Subscribers only |
<1%
|
5.12 | 2.91 | 3.77 | 4.54 | 2.71 | 3.46 | 4.10 | 2.34 | 5.09 | 4.11 | 3.21 | 2.57 | 2.86 | 2.95 | 3.07 | 3.55 | 3.11 | 4.40 | 2.43 | 4.00 | 2.56 | 3.77 | 4.67 | 3.11 | 2.16 | 2.18 | 2.73 | 4.85 | 2.61 | 3.89 | 1.96 | 3.38 | 3.44 | 3.35 | 3.25 | 3.95 | 2.75 | 3.42 | 3.10 | 23 | 3.36 | 4.22 | 1.88 | 2.73 | 3.52 | 2.65 | 3.89 | 2.46 | 2.75 | 3.86 | 3.58 | 3.45 | |||
| 68. | Subscribers only |
<1%
|
0.66 | 0.43 | 3.62 | 4.47 | 10 | 1.21 | 2.38 | 5.52 | 9.28 | 1.30 | 1.21 | 0.41 | 0.73 | 2.13 | 2.60 | 0.52 | 0.39 | 5.03 | 0.18 | 0.69 | 26 | 0.73 | 0.26 | 3.66 | 0.16 | 2.62 | 0 | 5.66 | 18 | 2.16 | 2.40 | 1.81 | 1.82 | 1.26 | 0.82 | 18 | 3.93 | 0.93 | 0.73 | 0.66 | 5.99 | 0.87 | 0.15 | 5.26 | 4.22 | 12 | 1.66 | 1.20 | 0.19 | 6.24 | 0.49 | 0.10 | |||
| 69. | Subscribers only |
<1%
|
1.24 | 1.46 | 1.24 | 1.57 | 1.42 | 1.95 | 3.67 | 2.50 | 3.77 | 4.21 | 4.13 | 5.33 | 4.20 | 3.39 | 4.13 | 4.69 | 5.84 | 3.43 | 4.26 | 4.81 | 3.06 | 3.91 | 5.06 | 5.93 | 0.56 | 4.69 | 2.35 | 5.11 | 4.53 | 3.34 | 3.35 | 5.26 | 3.51 | 4.55 | 6.71 | 1.92 | 2.71 | 1.52 | 2.27 | 2.16 | 2.38 | 3.43 | 2.94 | 1.57 | 3.39 | 4.63 | 3.40 | 1.86 | 2.87 | 3.28 | 1.45 | 2.48 | |||
| 70. | Subscribers only |
<1%
|
5.50 | 4.87 | 1.57 | 0.17 | 5.73 | 2.04 | 5.52 | 3.72 | 11 | 0.31 | 6.40 | 0 | 0.64 | 0 | 0.08 | 0 | 0.74 | 1.69 | 0.08 | 4.45 | 0.70 | 1.08 | 4.21 | 1.62 | 0.18 | 0.57 | 0.35 | 1.05 | 2.27 | 5.58 | 2.22 | 3.34 | 1.98 | 5.36 | 0.44 | 0.76 | 11 | 0.08 | 1.17 | 6.41 | 2.26 | 0.04 | 6.81 | 1.95 | 0 | 9.54 | 0.61 | 1.80 | 0 | 16 | 1.05 | 2.00 | |||
| 71. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 55 | 0 | 11 | 0 | 0.12 | 0 | 0 | 0 | 0 | 0.22 | 0 | 0 | 0.03 | 0.21 | 0 | 9.76 | 2.15 | 1.12 | 1.16 | 0.56 | 3.86 | 0 | 15 | 2.36 | 0 | 1.68 | 0.14 | 2.78 | 2.23 | 1.43 | 2.83 | 1.51 | 1.70 | 0 | 7.44 | 1.44 | 0.70 | 0 | 0 | 2.41 | |||
| 72. | Subscribers only |
<1%
|
2.15 | 1.95 | 2.34 | 3.51 | 1.44 | 1.94 | 1.17 | 3.66 | 3.75 | 2.20 | 2.53 | 1.19 | 1.07 | 3.98 | 1.46 | 2.29 | 1.37 | 2.38 | 1.54 | 1.10 | 1.73 | 0.92 | 1.84 | 2.96 | 1.87 | 1.70 | 2.02 | 1.10 | 1.56 | 0.92 | 2.18 | 1.11 | 1.63 | 1.21 | 3.07 | 0.89 | 2.23 | 3.77 | 2.84 | 1.97 | 2.71 | 2.35 | 2.76 | 0.25 | 1.14 | 4.02 | 0.59 | 4.63 | 1.36 | 7.17 | 7.36 | 7.14 | |||
| 73. | Subscribers only |
<1%
|
3.13 | 6.22 | 3.21 | 2.90 | 4.74 | 1.81 | 6.12 | 3.72 | 4.04 | 4.42 | 3.54 | 4.72 | 5.04 | 4.16 | 4.91 | 4.74 | 3.44 | 3.69 | 5.61 | 3.70 | 3.17 | 2.60 | 4.48 | 3.28 | 3.58 | 4.53 | 3.40 | 5.19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 74. | Subscribers only |
<1%
|
0.03 | 0.16 | 1.16 | 0.24 | 0.45 | 0.54 | 0.53 | 0.41 | 1.02 | 1.72 | 1.03 | 1.06 | 0.66 | 2.29 | 0.95 | 1.28 | 2.74 | 3.67 | 1.74 | 1.06 | 1.13 | 0.39 | 0.80 | 0 | 0.69 | 1.48 | 0.30 | 1.00 | 0.68 | 1.56 | 1.29 | 4.05 | 1.58 | 4.03 | 3.62 | 0.50 | 6.20 | 1.74 | 5.82 | 2.77 | 4.02 | 3.04 | 0.87 | 2.22 | 1.00 | 3.09 | 2.95 | 0.84 | 2.14 | 8.85 | 5.17 | 5.77 | |||
| 75. | Subscribers only |
<1%
|
2.61 | 3.05 | 4.97 | 0.58 | 2.81 | 1.51 | 2.07 | 1.13 | 3.91 | 1.39 | 3.49 | 1.95 | 0.75 | 0.83 | 3.15 | 2.33 | 2.56 | 3.03 | 2.16 | 0.97 | 1.45 | 2.81 | 0.55 | 0.94 | 1.25 | 0.43 | 4.81 | 1.26 | 1.30 | 11 | 1.51 | 4.02 | 2.14 | 1.72 | 0.90 | 2.08 | 0.81 | 0.49 | 1.38 | 0.63 | 0.84 | 1.32 | 1.10 | 2.49 | 1.81 | 0.41 | 0.95 | 1.34 | 1.52 | 1.05 | 1.98 | 0.36 | |||
| 76. | Subscribers only |
<1%
|
1.60 | 2.45 | 0.64 | 1.87 | 1.06 | 0.91 | 1.95 | 0.56 | 1.33 | 1.29 | 0.62 | 1.21 | 3.75 | 1.22 | 2.42 | 1.05 | 2.29 | 0.64 | 1.90 | 0.28 | 2.53 | 1.68 | 1.88 | 1.36 | 2.17 | 1.51 | 1.29 | 0.89 | 1.55 | 1.40 | 1.49 | 1.46 | 1.55 | 2.80 | 0.26 | 2.63 | 1.60 | 1.94 | 3.44 | 1.28 | 3.67 | 1.06 | 3.07 | 2.81 | 0.99 | 2.93 | 5.17 | 3.85 | 3.26 | 3.82 | 3.74 | 2.27 | |||
| 77. | Subscribers only |
<1%
|
1.08 | 2.25 | 1.34 | 1.51 | 2.09 | 0.82 | 1.81 | 0.80 | 1.81 | 1.69 | 1.89 | 1.71 | 1.67 | 1.35 | 1.03 | 0.99 | 1.37 | 1.11 | 1.47 | 1.86 | 0.89 | 2.17 | 1.63 | 2.26 | 1.72 | 0.94 | 0.89 | 1.39 | 1.53 | 1.35 | 1.01 | 0.98 | 1.63 | 1.53 | 0.80 | 1.61 | 1.21 | 1.04 | 1.55 | 1.36 | 2.43 | 1.50 | 1.56 | 1.45 | 1.39 | 0.83 | 2.50 | 2.00 | 1.22 | 22 | 1.67 | 1.18 | |||
| 78. | Subscribers only |
<1%
|
1.11 | 1.28 | 1.87 | 0.48 | 1.27 | 1.06 | 1.95 | 0.44 | 0.85 | 0.94 | 0.70 | 2.08 | 2.34 | 0.85 | 1.80 | 3.65 | 0.53 | 0.54 | 1.36 | 1.96 | 1.15 | 0.97 | 1.78 | 0.82 | 3.07 | 1.27 | 1.67 | 1.33 | 1.92 | 1.20 | 2.61 | 3.34 | 1.73 | 2.89 | 0.48 | 3.57 | 2.15 | 4.80 | 0.90 | 4.50 | 2.08 | 2.80 | 1.66 | 2.00 | 1.92 | 1.77 | 1.23 | 1.54 | 2.83 | 1.95 | 1.57 | 4.11 | |||
| 79. | Subscribers only |
<1%
|
1.76 | 0.93 | 2.03 | 2.82 | 2.00 | 3.56 | 3.51 | 1.70 | 2.45 | 4.01 | 1.64 | 2.68 | 2.60 | 1.36 | 1.81 | 2.11 | 1.31 | 2.87 | 2.52 | 2.44 | 0.86 | 0.93 | 0.64 | 0.86 | 0.77 | 0.60 | 2.79 | 0.83 | 1.18 | 0.81 | 1.11 | 0.72 | 2.87 | 1.75 | 1.51 | 0.69 | 0.50 | 1.13 | 2.84 | 0.58 | 1.00 | 2.04 | 1.38 | 2.86 | 2.70 | 0.78 | 1.10 | 0.53 | 1.08 | 1.38 | 0.70 | 2.01 | |||
| 80. | Subscribers only |
<1%
|
5.47 | 3.07 | 2.03 | 3.31 | 6.87 | 3.26 | 2.98 | 2.46 | 2.76 | 2.23 | 3.60 | 2.41 | 1.55 | 3.24 | 3.99 | 1.33 | 0.80 | 1.75 | 1.31 | 0.60 | 1.27 | 0.04 | 1.03 | 0.88 | 0.18 | 0.88 | 0.68 | 0.49 | 1.72 | 0.28 | 0.12 | 1.28 | 0.37 | 2.08 | 0.21 | 1.23 | 0.67 | 0.56 | 4.24 | 0.93 | 0.98 | 0.50 | 0.96 | 1.31 | 0.54 | 2.39 | 1.04 | 1.91 | 0.77 | 0.38 | 1.65 | 0.50 | |||
| 81. | Subscribers only |
<1%
|
0 | 0 | 0.86 | 0.89 | 0.56 | 0 | 1.36 | 0 | 0.73 | 0.75 | 0.76 | 0 | 0 | 0.78 | 1.22 | 0.40 | 2.07 | 0 | 3.57 | 1.28 | 2.78 | 0.39 | 1.38 | 2.87 | 1.50 | 0.34 | 4.49 | 0 | 1.74 | 3.90 | 1.76 | 0.25 | 0.51 | 3.02 | 2.87 | 2.94 | 0.78 | 2.15 | 0.33 | 2.98 | 4.92 | 1.56 | 0 | 2.57 | 2.52 | 0.09 | 0 | 6.47 | 2.89 | 1.21 | 6.26 | 2.92 | |||
| 82. | Subscribers only |
<1%
|
0.19 | 1.73 | 0.75 | 0.97 | 2.19 | 2.75 | 3.00 | 0.57 | 0.54 | 2.37 | 0.88 | 1.84 | 1.72 | 2.33 | 1.00 | 2.28 | 2.55 | 0.31 | 0.80 | 1.86 | 0.92 | 2.41 | 2.08 | 1.97 | 1.19 | 0.32 | 0.66 | 1.94 | 0.34 | 1.35 | 1.04 | 2.61 | 1.19 | 1.82 | 0.33 | 0.90 | 0.94 | 1.89 | 1.90 | 3.19 | 0.76 | 2.59 | 1.45 | 1.19 | 2.30 | 1.97 | 3.27 | 1.94 | 1.28 | 1.09 | 1.98 | 2.96 | |||
| 83. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.15 | 14 | 23 | 4.13 | 0 | 0 | 0 | 0.26 | 0 | 0 | 0 | 0 | 9.27 | 25 | 0 | 0 | |||
| 84. | Subscribers only |
<1%
|
0 | 2.27 | 0.59 | 1.74 | 14 | 1.66 | 0.55 | 1.08 | 1.52 | 1.07 | 0.28 | 0 | 2.38 | 1.54 | 0.04 | 0.57 | 3.01 | 0.72 | 0 | 2.68 | 2.09 | 1.45 | 10 | 0.13 | 1.73 | 1.24 | 0.92 | 1.45 | 2.98 | 0.65 | 1.27 | 1.74 | 1.45 | 0.99 | 2.39 | 1.51 | 0.97 | 0 | 0.45 | 0.06 | 0.61 | 0.82 | 0.33 | 0.09 | 0 | 0 | 0.61 | 0.71 | 0.03 | 0.64 | 0.07 | 0 | |||
| 85. | Subscribers only |
<1%
|
7.30 | 1.09 | 0.25 | 0.23 | 7.90 | 1.32 | 4.31 | 0.23 | 0.31 | 5.50 | 0.98 | 0.99 | 0.05 | 0.71 | 0.52 | 0 | 11 | 1.20 | 0 | 0.22 | 1.33 | 1.59 | 0.04 | 4.91 | 0.17 | 0.07 | 0 | 1.59 | 0.40 | 0.06 | 1.82 | 1.88 | 0.60 | 0.33 | 1.98 | 0.45 | 0.04 | 0.19 | 0 | 0.05 | 0.27 | 0.04 | 0 | 1.03 | 0.06 | 0.08 | 0.03 | 1.95 | 0.08 | 2.19 | 0.87 | 2.28 | |||
| 86. | Subscribers only |
<1%
|
0.99 | 1.37 | 1.13 | 0.73 | 0.74 | 1.21 | 2.29 | 2.14 | 1.97 | 1.06 | 2.02 | 2.33 | 0.95 | 0.39 | 0.63 | 0.65 | 0.14 | 0.96 | 0.68 | 1.09 | 0.03 | 1.37 | 0.58 | 1.48 | 0.79 | 3.05 | 1.19 | 3.15 | 0.71 | 0.13 | 1.81 | 0.66 | 2.83 | 2.18 | 0.09 | 1.71 | 0.55 | 2.73 | 0.72 | 0.66 | 1.14 | 0.98 | 1.28 | 2.00 | 0.16 | 2.53 | 1.54 | 1.27 | 0.44 | 1.08 | 1.51 | 1.98 | |||
| 87. | Subscribers only |
<1%
|
0.71 | 0.92 | 1.68 | 0.23 | 1.24 | 1.60 | 0.10 | 1.95 | 1.07 | 0.95 | 1.32 | 0.81 | 0.93 | 0.81 | 1.16 | 0.62 | 1.56 | 0.72 | 1.56 | 1.00 | 1.51 | 0.87 | 0.78 | 2.54 | 0.98 | 0.09 | 2.48 | 1.23 | 2.27 | 3.48 | 1.19 | 1.87 | 1.81 | 0.09 | 2.07 | 1.38 | 0.44 | 1.32 | 1.07 | 1.88 | 1.15 | 2.10 | 0.82 | 1.95 | 2.31 | 0.40 | 2.08 | 0 | 0.73 | 1.52 | 0.45 | 1.68 | |||
| 88. | Subscribers only |
<1%
|
1.21 | 1.51 | 2.75 | 0.89 | 2.07 | 3.13 | 1.70 | 0.89 | 0.99 | 1.41 | 1.22 | 0.65 | 0.24 | 1.26 | 1.39 | 0.45 | 2.16 | 0.97 | 0.78 | 0.60 | 0.60 | 0.24 | 1.36 | 0.40 | 0.19 | 0.55 | 0.81 | 1.39 | 0.75 | 0.68 | 2.01 | 0.50 | 0.61 | 1.48 | 1.53 | 0.15 | 1.78 | 2.41 | 1.76 | 1.49 | 2.08 | 0.60 | 2.39 | 0.86 | 0.98 | 2.11 | 0.89 | 1.44 | 1.05 | 1.39 | 3.02 | 0.68 | |||
| 89. | Botswana |
<1%
|
3.10 | 0 | 0.89 | 0 | 1.01 | 0.66 | 1.29 | 0.16 | 0 | 0.15 | 1.06 | 0.87 | 1.27 | 0.30 | 0 | 0.04 | 0 | 1.18 | 3.45 | 0.25 | 0 | 1.17 | 0 | 1.58 | 0 | 0.95 | 0 | 0 | 0.99 | 1.20 | 1.49 | 0.16 | 3.13 | 0.13 | 1.35 | 2.35 | 2.77 | 1.09 | 3.06 | 0.52 | 7.72 | 0.30 | 0.25 | 1.92 | 2.21 | 1.92 | 3.56 | 1.30 | 1.11 | 0.78 | 0 | 2.38 | |||
| 90. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.04 | 2.45 | 2.91 | 3.39 | 3.61 | 2.78 | 2.27 | 3.23 | 1.60 | 1.99 | 4.47 | 4.28 | 2.02 | 0.72 | 2.12 | 2.58 | 2.56 | 3.13 | 3.66 | 2.21 | 1.65 | 2.06 | 2.38 | |||
| 91. | Subscribers only |
<1%
|
0.31 | 0.15 | 0.20 | 0.39 | 31 | 0 | 0.36 | 0.18 | 0.16 | 0.14 | 0.17 | 0.14 | 0 | 0.14 | 0 | 0.35 | 0.35 | 0.06 | 0.16 | 0.26 | 0.16 | 0.65 | 0 | 0.17 | 0.10 | 0.05 | 0.20 | 0.85 | 0.17 | 0.57 | 1.29 | 0.50 | 0.47 | 0.11 | 0.61 | 0.13 | 0.06 | 0.21 | 0.40 | 0.19 | 0.70 | 3.22 | 0.78 | 0.03 | 0.66 | 0.44 | 0.13 | 0 | 0.59 | 0.56 | 0.63 | 0.66 | |||
| 92. | Subscribers only |
<1%
|
0.15 | 0.59 | 0.48 | 0.33 | 1.23 | 0.75 | 1.19 | 0.20 | 1.25 | 1.48 | 0.96 | 1.07 | 1.33 | 0.24 | 0.59 | 0.25 | 0.55 | 0 | 0.36 | 7.45 | 1.07 | 0.31 | 0.14 | 0.16 | 0.81 | 0.94 | 0.72 | 0.76 | 1.37 | 1.18 | 0.49 | 2.36 | 1.08 | 1.98 | 0.29 | 1.14 | 0.38 | 0.46 | 1.26 | 0.20 | 0.63 | 0.66 | 1.02 | 1.28 | 0.45 | 0.95 | 1.90 | 0.17 | 0.43 | 1.29 | 2.30 | 1.00 | |||
| 93. | Subscribers only |
<1%
|
1.56 | 0.18 | 0.11 | 0.05 | 0.03 | 0.28 | 0 | 1.46 | 0.46 | 0.06 | 0 | 3.13 | 2.61 | 1.25 | 0.36 | 0.39 | 0.04 | 8.57 | 6.73 | 0.68 | 0.04 | 0.13 | 0.31 | 0.16 | 0.16 | 0.03 | 0.25 | 0 | 0.07 | 0.10 | 0.19 | 0.47 | 0.36 | 0.32 | 0.37 | 0.12 | 0.20 | 1.77 | 11 | 2.24 | 0.22 | 0.60 | 0.20 | 0.53 | 0.09 | 0.21 | 0.13 | 0.03 | 0.19 | 0.18 | 0.26 | 0.20 | |||
| 94. | Subscribers only |
<1%
|
0.64 | 0.59 | 0 | 0 | 0.95 | 0.62 | 0.91 | 1.00 | 0.12 | 1.03 | 0 | 2.11 | 0.09 | 1.54 | 0.31 | 1.71 | 0.05 | 1.87 | 0 | 0.11 | 0.97 | 0.36 | 1.15 | 0.28 | 3.03 | 0.14 | 0.35 | 2.21 | 1.46 | 0.18 | 2.16 | 0.23 | 1.17 | 1.05 | 0.84 | 1.57 | 2.03 | 0.27 | 2.37 | 1.40 | 0.82 | 0.11 | 0.07 | 1.37 | 1.62 | 2.06 | 1.08 | 0.47 | 1.14 | 0.07 | 1.40 | 0.54 | |||
| 95. | Subscribers only |
<1%
|
0.38 | 0.28 | 0.07 | 1.41 | 1.06 | 1.29 | 1.46 | 0 | 0 | 0.32 | 0 | 1.08 | 0.18 | 0.39 | 0.37 | 0 | 0 | 1.88 | 0.62 | 0 | 0 | 1.11 | 3.50 | 0.62 | 0.94 | 0 | 2.36 | 0 | 0 | 1.15 | 0.59 | 0 | 0.79 | 0.07 | 0.79 | 0.46 | 0 | 1.67 | 1.28 | 2.13 | 4.69 | 0.03 | 0 | 0 | 0 | 1.80 | 3.40 | 0 | 0.29 | 2.18 | 0.75 | 0.93 | |||
| 96. | Subscribers only |
<1%
|
0 | 0.36 | 3.18 | 0 | 3.50 | 0.10 | 1.68 | 0.06 | 0 | 0 | 0.21 | 0 | 0 | 0 | 0.09 | 0.05 | 0 | 0 | 0 | 0 | 0.27 | 0 | 0 | 0.34 | 0.20 | 0.21 | 0.14 | 0 | 0.49 | 0 | 0.23 | 0.15 | 0 | 0 | 0 | 1.33 | 2.61 | 1.52 | 1.49 | 3.27 | 1.14 | 1.06 | 2.45 | 0.42 | 0.23 | 1.48 | 6.94 | 1.07 | 0.54 | 0.92 | 1.94 | 0.05 | |||
| 97. | Subscribers only |
<1%
|
0.26 | 0.36 | 0.41 | 0.64 | 2.22 | 0.44 | 0.68 | 0.32 | 0.17 | 0.84 | 0.58 | 0.68 | 0.03 | 1.16 | 0.09 | 0.44 | 1.23 | 0.86 | 0.80 | 0.32 | 1.06 | 0.97 | 0.47 | 0.76 | 1.43 | 0.98 | 0.59 | 1.57 | 0 | 0.62 | 0.03 | 0.51 | 0.50 | 0.51 | 0.34 | 0.35 | 2.20 | 0 | 1.29 | 1.12 | 0.26 | 0.46 | 1.09 | 0.46 | 0.45 | 0.48 | 0.15 | 2.33 | 0.34 | 1.95 | 1.46 | 1.62 | |||
| 98. | Subscribers only |
<1%
|
0.51 | 1.28 | 0.52 | 0.90 | 0.46 | 0.59 | 1.17 | 1.41 | 0.12 | 0.06 | 1.57 | 1.93 | 1.03 | 0.10 | 0.11 | 0 | 2.40 | 0.38 | 0.67 | 0.35 | 0.50 | 1.00 | 0.55 | 0.64 | 0.33 | 1.39 | 0.29 | 1.09 | 0.81 | 1.16 | 1.27 | 0.56 | 0.41 | 0.44 | 0.78 | 0.70 | 0.18 | 0.74 | 0.74 | 0.43 | 0.20 | 0.33 | 1.60 | 0.27 | 0.51 | 0.99 | 0.73 | 0.28 | 0.61 | 0.94 | 0.35 | 0.73 | |||
| 99. | Subscribers only |
<1%
|
0.08 | 1.07 | 1.18 | 0.86 | 2.12 | 0.36 | 2.31 | 0.14 | 1.41 | 0.99 | 2.14 | 0.71 | 0.04 | 0.13 | 0.37 | 0.27 | 0.53 | 0.34 | 0.29 | 0.28 | 0.21 | 0.62 | 0.67 | 0.52 | 0.21 | 1.01 | 0.17 | 0.81 | 0.53 | 0.06 | 1.18 | 1.10 | 0.58 | 1.54 | 0 | 0.67 | 0 | 0.39 | 1.41 | 0.40 | 0.55 | 1.24 | 0.38 | 0.60 | 2.10 | 0.32 | 0.13 | 0.59 | 0.04 | 0.42 | 1.48 | 1.35 | |||
| 100. | Subscribers only |
<1%
|
0 | 0.10 | 0.13 | 34 | 0.08 | 0.29 | 0.19 | 0 | 0.21 | 0 | 0.42 | 0 | 0.07 | 0 | 0.06 | 0.03 | 0 | 0.11 | 0 | 0 | 0 | 0.03 | 0.04 | 0.03 | 0.50 | 0.03 | 0.03 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0.20 | 0.05 | 0.14 | 0 | 0 | 0.09 | 0 | 0.03 | 0 | 0.03 | 0 | 0.05 | 0 | 0.19 | 0.06 | 0 | 0.08 | 0 | |||
| 101. | Subscribers only |
<1%
|
0.67 | 0 | 0.75 | 4.15 | 0 | 0 | 0.51 | 2.03 | 0.67 | 0.41 | 1.78 | 0.73 | 0 | 0.05 | 1.88 | 0 | 2.82 | 2.44 | 0.91 | 1.28 | 0.57 | 5.98 | 0.91 | 0 | 0 | 0.68 | 1.29 | 0 | 0.53 | 0 | 0.75 | 1.38 | 0 | 0.21 | 0 | 0.66 | 0.20 | 0 | 0.87 | 0 | 0 | 0 | 0 | 0.30 | 0 | 0 | 0.28 | 0 | 0 | 0 | 0.43 | 0 | |||
| 102. | Subscribers only |
<1%
|
0 | 0.60 | 0 | 0 | 0.39 | 0.34 | 0.29 | 0 | 0.20 | 0.38 | 0 | 0 | 0 | 0.03 | 0 | 0.04 | 0.30 | 0 | 0.30 | 0 | 2.36 | 0.04 | 0.66 | 0 | 1.30 | 0.30 | 0.11 | 0.05 | 0.07 | 1.32 | 0.12 | 0.03 | 0 | 0.16 | 7.58 | 0.32 | 0.55 | 1.15 | 0.26 | 1.21 | 0 | 0 | 0 | 0.76 | 0.27 | 0.05 | 6.70 | 0.40 | 2.27 | 2.52 | 0.49 | 1.26 | |||
| 103. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.81 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.07 | 2.02 | 0 | 2.02 | 1.96 | 0 | 0 | 1.02 | 0.77 | 2.94 | 1.89 | 0 | 2.90 | 2.90 | 1.62 | 0 | 0 | 0.69 | 2.06 | 0.69 | 0.93 | 2.42 | 2.02 | 0 | 0 | 0 | 0.59 | 0 | 0 | 1.41 | 0 | 0 | |||
| 104. | Subscribers only |
<1%
|
0 | 0.05 | 0 | 0 | 0.07 | 0 | 2.76 | 1.88 | 1.20 | 0.79 | 0.18 | 0.72 | 1.77 | 5.40 | 1.62 | 0.67 | 1.93 | 0.89 | 0.73 | 0.59 | 0.03 | 0.78 | 2.87 | 0 | 0.25 | 0.70 | 0.26 | 0 | 1.02 | 1.01 | 0.20 | 0 | 0.03 | 0.06 | 0.03 | 1.88 | 0 | 0 | 0 | 0 | 0.09 | 0 | 0.19 | 0 | 0 | 0.07 | 0 | 0.30 | 0.06 | 0.07 | 0 | 0.37 | |||
| 105. | Subscribers only |
<1%
|
0.09 | 0.59 | 0.41 | 0.09 | 0.24 | 0.10 | 0.45 | 0.13 | 0 | 0.65 | 0.03 | 0.22 | 0.48 | 0.13 | 0.10 | 0 | 0.27 | 0.09 | 0.22 | 0.04 | 0 | 0.14 | 0.05 | 0.09 | 0.52 | 1.05 | 0 | 0.40 | 0.10 | 0.17 | 0.61 | 0.22 | 0.08 | 3.61 | 0.46 | 0.78 | 0 | 0.57 | 0 | 0.21 | 0.12 | 0.13 | 0.29 | 0.08 | 0 | 5.56 | 0.35 | 0.13 | 0.21 | 8.73 | 1.35 | 0.30 | |||
| 106. | Subscribers only |
<1%
|
0.39 | 1.26 | 0.14 | 1.65 | 0.47 | 0 | 1.30 | 0 | 0.52 | 0.15 | 0 | 0.28 | 0.09 | 0.74 | 0.51 | 0 | 0.28 | 0.83 | 1.19 | 1.01 | 0.31 | 0.49 | 0.05 | 0.69 | 0.04 | 0.30 | 0.55 | 0.05 | 0.07 | 0.61 | 0.05 | 0 | 0.24 | 0.58 | 0.09 | 0.32 | 0.04 | 0.17 | 4.98 | 0.17 | 1.18 | 1.96 | 0.67 | 0.32 | 0.54 | 0.72 | 0 | 1.08 | 2.09 | 0.18 | 0.35 | 0.91 | |||
| 107. | Subscribers only |
<1%
|
0.08 | 1.10 | 0.57 | 0.18 | 1.40 | 0.79 | 0.18 | 1.44 | 0.32 | 0.22 | 0.81 | 0 | 0.45 | 0.16 | 1.31 | 0.69 | 0.19 | 0.83 | 0.37 | 0.04 | 0.69 | 0.16 | 1.84 | 0.43 | 0.72 | 1.17 | 1.14 | 0.43 | 0.15 | 0.64 | 0.15 | 0.19 | 0.60 | 0.18 | 0.52 | 0.21 | 1.33 | 0.84 | 0.03 | 0.52 | 1.61 | 0.06 | 0.06 | 0.92 | 0.24 | 0.07 | 0.85 | 0.18 | 0.04 | 0.29 | 0.15 | 0.50 | |||
| 108. | Subscribers only |
<1%
|
0 | 0.20 | 1.15 | 0.26 | 1.10 | 0.74 | 0.22 | 0.77 | 0 | 0.44 | 0.67 | 0.10 | 0.26 | 0.54 | 0.65 | 0.54 | 0.53 | 3.15 | 0.80 | 1.50 | 0.09 | 0.77 | 0.22 | 1.82 | 0.23 | 0.10 | 0.48 | 0.79 | 0.39 | 0.07 | 0.10 | 0.08 | 0.03 | 0.12 | 0.15 | 0.14 | 0 | 0.18 | 0.36 | 0.50 | 0.48 | 0.12 | 0.16 | 0.36 | 0.28 | 0.36 | 0.35 | 0.59 | 0.43 | 2.00 | 0 | 1.54 | |||
| 109. | Subscribers only |
<1%
|
0.04 | 0 | 0.12 | 0.41 | 0.81 | 1.72 | 0 | 0 | 0 | 0.42 | 1.88 | 0.46 | 0.59 | 0.03 | 0.29 | 0.06 | 0.37 | 0.19 | 0.09 | 0.07 | 0.35 | 0.54 | 0.32 | 0.15 | 0.85 | 0.18 | 0.09 | 0.23 | 2.06 | 0.44 | 1.08 | 0.14 | 0.23 | 0.23 | 0.24 | 0.52 | 0.92 | 0.77 | 0.33 | 0.37 | 0.47 | 0.18 | 0.31 | 2.06 | 0.54 | 0.85 | 0.39 | 0.79 | 0.99 | 0.41 | 0.22 | 1.05 | |||
| 110. | Subscribers only |
<1%
|
0.03 | 0 | 0.07 | 0.03 | 0.29 | 0 | 0 | 0.10 | 16 | 0.19 | 0.25 | 0.18 | 0.07 | 0.04 | 0.05 | 0.12 | 0.25 | 0.05 | 0.04 | 0.04 | 0.15 | 0.36 | 0.51 | 0.57 | 0 | 0 | 0.14 | 0.39 | 0.21 | 0.23 | 0.51 | 0.05 | 0.36 | 0.05 | 0.07 | 0.03 | 0.16 | 0.06 | 0.52 | 0.40 | 0.33 | 0 | 0.55 | 0.05 | 0 | 0 | 0.10 | 0 | 0.11 | 0.70 | 0.38 | 0.06 | |||
| 111. | Subscribers only |
<1%
|
0 | 1.13 | 0.19 | 0.19 | 0.19 | 1.26 | 0.75 | 0.10 | 0.33 | 2.83 | 0.76 | 0.03 | 0 | 0 | 0.14 | 0.03 | 0.97 | 0 | 0.27 | 0 | 1.71 | 0 | 0.05 | 0.04 | 0 | 0.05 | 0.17 | 0 | 0 | 0 | 0.09 | 0.10 | 0 | 0.61 | 0 | 0.89 | 0 | 0.14 | 1.40 | 0 | 1.48 | 0 | 0.06 | 0.78 | 1.27 | 0.70 | 3.78 | 0.56 | 0.12 | 0.37 | 0.73 | 0.18 | |||
| 112. | Subscribers only |
<1%
|
0 | 1.65 | 4.26 | 7.71 | 4.75 | 3.30 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0 | 0 | 1.31 | 0 | 0 | 0 | 0 | 0 | |||
| 113. | Subscribers only |
<1%
|
0 | 0 | 0 | 0.20 | 0.99 | 0 | 0.08 | 0 | 0 | 0.64 | 0 | 0 | 0.31 | 0 | 0.40 | 0.82 | 0.03 | 0.14 | 0.71 | 0.14 | 0.04 | 3.43 | 0.29 | 0 | 0.11 | 0.10 | 0.05 | 0 | 0 | 0 | 0 | 1.96 | 0 | 0 | 0 | 2.70 | 0 | 0 | 1.86 | 0 | 0 | 0 | 1.18 | 1.90 | 0.67 | 0.58 | 0.48 | 0.55 | 2.08 | 0.19 | 0 | 0 | |||
| 114. | Subscribers only |
<1%
|
0.16 | 2.43 | 0.83 | 0.72 | 1.20 | 1.13 | 2.37 | 0.63 | 0.56 | 0.44 | 0.12 | 0.05 | 0 | 0.25 | 0.29 | 0.33 | 0.10 | 0 | 0.19 | 0 | 0.65 | 0.46 | 0.51 | 0 | 0.04 | 0.05 | 0.42 | 0.32 | 0.89 | 0.12 | 0.10 | 0.28 | 0.73 | 0.29 | 0.26 | 0.34 | 0.04 | 0.15 | 0.90 | 0.03 | 0.05 | 0.22 | 1.15 | 0.19 | 0.40 | 0.42 | 0.48 | 0.06 | 0.12 | 0.65 | 0.31 | 0.11 | |||
| 115. | Subscribers only |
<1%
|
0.17 | 0.42 | 0.42 | 0.72 | 0.21 | 0 | 0 | 0 | 0 | 0.42 | 0.04 | 0.03 | 0 | 0.42 | 0.16 | 0 | 0 | 0 | 0.50 | 0 | 0 | 1.84 | 0.39 | 0 | 0.33 | 0.14 | 0.04 | 0.72 | 0.26 | 1.01 | 0 | 0 | 0 | 0.82 | 0 | 0.06 | 0 | 0.58 | 0.07 | 0.42 | 0 | 7.96 | 1.49 | 0 | 0.53 | 0.06 | 0.03 | 0 | 1.06 | 0 | 0.03 | 0.23 | |||
| 116. | Subscribers only |
<1%
|
0.13 | 0.77 | 0.17 | 0.76 | 0.53 | 0.25 | 0.58 | 0.18 | 0.41 | 1.09 | 0.30 | 0.33 | 0.18 | 0.44 | 0.30 | 0.42 | 0.47 | 0.26 | 0.14 | 0.24 | 0.18 | 0.54 | 0.11 | 0.40 | 0.14 | 0.10 | 0.55 | 0.80 | 0.23 | 0.34 | 0.39 | 0.38 | 0.33 | 0.17 | 0.48 | 0.06 | 0.68 | 0.18 | 0.72 | 0.27 | 0.53 | 0.83 | 0.17 | 0.21 | 0.21 | 0.23 | 0.19 | 0 | 1.78 | 0.43 | 0.08 | 0.57 | |||
| 117. | Subscribers only |
<1%
|
0 | 0 | 0.25 | 0.45 | 0.05 | 0 | 0 | 0 | 0 | 0.15 | 0.07 | 0.03 | 0.03 | 0.23 | 0.04 | 0.81 | 0.31 | 0.43 | 0.10 | 0.53 | 0.09 | 0 | 0.22 | 1.55 | 0.43 | 0.15 | 0.56 | 0.56 | 1.49 | 0.59 | 0 | 0.12 | 0.22 | 0.06 | 1.05 | 0.42 | 0 | 0.20 | 0.15 | 0.12 | 4.11 | 0.90 | 0.22 | 0.16 | 0.38 | 0.35 | 0.11 | 0.41 | 0.77 | 0.30 | 0.21 | 0.33 | |||
| 118. | Subscribers only |
<1%
|
0.03 | 2.52 | 0.11 | 8.59 | 0.22 | 0 | 0 | 0 | 0 | 0.07 | 0.24 | 0 | 0.15 | 0 | 0 | 0.20 | 0.12 | 0.04 | 0.08 | 0 | 0 | 0.08 | 0 | 0 | 0.31 | 0.04 | 0 | 0 | 0.15 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0 | 0.20 | 0.80 | 0 | 1.14 | 0 | 0 | 0.08 | 0.99 | 0 | 0 | 0.45 | 0 | 0 | 0.57 | 0.19 | |||
| 119. | Subscribers only |
<1%
|
0 | 0.07 | 0 | 0.08 | 0.29 | 0.08 | 0.65 | 0 | 0.13 | 0.29 | 0 | 0.63 | 0.09 | 0 | 0.07 | 0.91 | 0 | 0.09 | 0 | 0.07 | 0.14 | 0.04 | 1.51 | 1.56 | 0 | 0.03 | 0.10 | 0.06 | 0.07 | 0 | 0 | 0 | 0.86 | 0 | 0 | 0 | 0.15 | 0.09 | 0.07 | 0 | 0 | 0 | 2.44 | 0 | 0.03 | 0.03 | 0 | 2.17 | 0.03 | 0.05 | 0.27 | 0.04 | |||
| 120. | Subscribers only |
<1%
|
1.28 | 0.03 | 0 | 0 | 0.05 | 0.76 | 0.18 | 0.15 | 0.18 | 0 | 0.08 | 0 | 0.09 | 0.06 | 0.34 | 0.03 | 0.07 | 0.04 | 0 | 0.13 | 0 | 0.04 | 0.66 | 0.11 | 0.57 | 0 | 0 | 0.21 | 0.18 | 0.04 | 0 | 1.04 | 0.05 | 0 | 0.82 | 0 | 0 | 1.06 | 0.03 | 0 | 0 | 0.71 | 0 | 0 | 0.83 | 0 | 1.88 | 0.04 | 0 | 0.06 | 1.12 | 0.13 | |||
| 121. | Subscribers only |
<1%
|
0.08 | 0.15 | 0.21 | 0.14 | 0.66 | 0.16 | 0 | 0.11 | 0.11 | 0 | 0.27 | 0.17 | 0.27 | 0.73 | 0.23 | 0.14 | 0.16 | 0 | 0 | 0.55 | 0.33 | 0 | 0.24 | 0.34 | 0.25 | 0.16 | 0.13 | 0.52 | 0 | 0.69 | 0.04 | 0.91 | 0.24 | 0.69 | 0 | 0.26 | 0.38 | 0 | 0.07 | 0.12 | 0.33 | 0.04 | 0.07 | 0.19 | 1.38 | 0.53 | 0 | 0.35 | 0 | 0.14 | 0.08 | 0.12 | |||
| 122. | Subscribers only |
<1%
|
0.24 | 3.18 | 0.21 | 0.40 | 0.08 | 0 | 0.78 | 0.03 | 0.04 | 0.31 | 0.11 | 0.06 | 0.25 | 0.18 | 0.14 | 0.23 | 0 | 0.06 | 0.03 | 0 | 0.20 | 0.10 | 0.27 | 0.14 | 0.62 | 0.08 | 0.06 | 0.24 | 0 | 0 | 0.07 | 0.09 | 0.17 | 0.19 | 0.03 | 0.27 | 0.86 | 0.21 | 1.17 | 0.13 | 0.18 | 0.19 | 0 | 0.23 | 0.40 | 0.09 | 0 | 0 | 0.06 | 0.27 | 0.07 | 0 | |||
| 123. | Subscribers only |
<1%
|
0.06 | 0.99 | 0 | 0.58 | 0.75 | 0.37 | 0.16 | 1.21 | 0.08 | 0.06 | 0.50 | 0.39 | 0 | 0 | 0.38 | 0.54 | 0.22 | 0.22 | 0.12 | 0.08 | 0.07 | 0.03 | 1.33 | 0.14 | 0.03 | 0.04 | 0.03 | 0.20 | 0.04 | 0.28 | 0.08 | 0.03 | 0.23 | 0.19 | 0.15 | 0.04 | 0 | 0.19 | 0.04 | 0.13 | 0.05 | 0.37 | 0 | 0.10 | 0.04 | 0.37 | 0 | 0.08 | 0 | 0.05 | 0.35 | 0 | |||
| 124. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.49 | 0.26 | 0.41 | 0.27 | 0.34 | 0.77 | 0.37 | 0.31 | 0.52 | 0.78 | 0.13 | 0.76 | 0.42 | 0.40 | 0.24 | 0.41 | 0.30 | 0.39 | 0.38 | 0.67 | 1.58 | 0.48 | 0.69 | |||
| 125. | Subscribers only |
<1%
|
0 | 0.03 | 0 | 1.03 | 0.07 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0 | 0 | 1.10 | 0 | 0.04 | 0 | 0 | 0 | 0.73 | 0 | 0.84 | 0 | 0 | 0 | 0 | 2.52 | 0 | 0 | 0.04 | 0 | 1.68 | 0 | 0 | 0 | 0 | 1.68 | 0 | 0.03 | 0 | 0 | 0 | 1.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 126. | Subscribers only |
<1%
|
0 | 0 | 0.03 | 9.23 | 0.26 | 0.61 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0.64 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 127. | Subscribers only |
<1%
|
0 | 0.42 | 0.24 | 0 | 0 | 0 | 0 | 0 | 0.29 | 0 | 0 | 0 | 0 | 0 | 0.39 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0.05 | 0.38 | 0.15 | 0 | 0 | 0 | 0 | 0 | 0.35 | 0 | 0.47 | 0.18 | 0 | 0 | 0 | 0 | 0.18 | 0 | 0.21 | 0.56 | 0 | 0.17 | 0 | 0 | 0 | 0.04 | 0 | 6.62 | 0 | 0 | 0 | |||
| 128. | Subscribers only |
<1%
|
0.13 | 0 | 0 | 0 | 0 | 0.26 | 0 | 0 | 0.26 | 0.27 | 0 | 0 | 0.14 | 0.47 | 0 | 0 | 0 | 0 | 0 | 0 | 0.16 | 0 | 0.68 | 0 | 0 | 0 | 0 | 0.37 | 0 | 0 | 0.17 | 0 | 0 | 0.83 | 0.51 | 0.24 | 0 | 0.14 | 1.97 | 0.29 | 0 | 0.07 | 0.91 | 0.45 | 0.35 | 0 | 0.79 | 0 | 0 | 0.12 | 0.99 | 0 | |||
| 129. | Subscribers only |
<1%
|
0.11 | 0.15 | 0.56 | 0.26 | 0.42 | 0.23 | 0.20 | 0.33 | 0.21 | 0.16 | 0.28 | 0 | 0.06 | 0.21 | 0.05 | 0.43 | 0.08 | 0.04 | 0.24 | 0.07 | 0.12 | 0.35 | 0.06 | 0.17 | 0.13 | 0.06 | 0.11 | 0.11 | 0.14 | 0.18 | 0.32 | 0.22 | 0.13 | 0.17 | 0.11 | 0.32 | 0.15 | 0.09 | 0.40 | 0.17 | 0.33 | 0.08 | 0.05 | 0.24 | 0.17 | 0.24 | 0.09 | 0 | 0.03 | 0.13 | 0.37 | 0.65 | |||
| 130. | Subscribers only |
<1%
|
0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0.05 | 0 | 0 | 0.05 | 0.87 | 0.03 | 0.09 | 0.10 | 0.12 | 0.14 | 0.25 | 0 | 0 | 0.16 | 0 | 0.14 | 0.11 | 0.55 | 0.29 | 0.11 | 0.21 | 0.25 | 0.31 | 0.15 | 0.21 | 0.42 | 0.31 | 0.72 | 0.07 | 0.11 | 0.25 | 0.43 | 0.39 | 0.38 | 0.28 | 0.60 | 0.09 | 0.78 | 0.15 | 0.51 | 0.23 | |||
| 131. | Subscribers only |
<1%
|
0 | 0.43 | 0.18 | 0.04 | 0.57 | 0.03 | 0.80 | 0.03 | 0 | 0.08 | 0 | 0.40 | 0.19 | 0.06 | 0.18 | 0.61 | 0.36 | 0.75 | 0.10 | 0.18 | 0.24 | 0.09 | 0.10 | 0.14 | 0 | 0 | 0.08 | 0.06 | 0.22 | 0.11 | 0.07 | 0.15 | 0.11 | 0.11 | 0.05 | 0.20 | 0.11 | 0.21 | 0.16 | 0.11 | 0.03 | 0.24 | 0 | 0.11 | 0.11 | 0.14 | 0.18 | 0.38 | 0.22 | 0.28 | 0.25 | 0.35 | |||
| 132. | Subscribers only |
<1%
|
0.22 | 0.67 | 0.17 | 0.27 | 0.35 | 0.55 | 0.14 | 0.39 | 0.06 | 0.84 | 0.35 | 0.34 | 0.20 | 0.21 | 0.38 | 0.03 | 0.04 | 0.08 | 0 | 0.19 | 0.05 | 0.14 | 0.14 | 0.15 | 0.17 | 0.03 | 0.40 | 0.07 | 0.03 | 0.47 | 0.18 | 0 | 0.06 | 0.21 | 0.20 | 0.04 | 0.05 | 0.13 | 0.09 | 0.11 | 0.10 | 0.03 | 0.12 | 0.03 | 0.03 | 0 | 0.64 | 0.26 | 0 | 0.08 | 0 | 0.04 | |||
| 133. | Subscribers only |
<1%
|
0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0.41 | 0.70 | 0 | 0 | 0 | 0.31 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 6.97 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.14 | 0 | 0 | 0.34 | 0 | 0.49 | 0.04 | 0 | |||
| 134. | Subscribers only |
<1%
|
0 | 1.75 | 1.77 | 0 | 2.12 | 0 | 1.25 | 1.26 | 1.16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 135. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0.55 | 0.97 | 1.26 | 0 | 0 | 0 | 0.07 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.74 | 0 | 0 | 0 | 0 | 0.78 | 0 | 0 | 0.03 | 0 | 1.76 | 0 | 0 | 0 | 0 | 0 | 1.39 | 0 | 0 | 0 | 0.09 | 1.67 | |||
| 136. | Subscribers only |
<1%
|
0 | 0 | 0 | 0.96 | 0 | 0.35 | 0.96 | 0 | 0 | 0 | 0 | 0 | 2.07 | 0 | 0 | 0 | 0.04 | 0.44 | 0 | 0.87 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.12 | 0 | 0 | 0.08 | 0 | 0.10 | 0.94 | 0 | 0 | 0.05 | 0.09 | 0.04 | 0.04 | 0 | 0.65 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 137. | Subscribers only |
<1%
|
0 | 0.28 | 0.38 | 0.33 | 0.32 | 0.03 | 0 | 0 | 0 | 0.03 | 0.03 | 0.33 | 0.19 | 0.18 | 0.59 | 0.36 | 0 | 0 | 0 | 0.06 | 0.07 | 0.04 | 0 | 0.13 | 0 | 0.03 | 0.12 | 0 | 0.07 | 0 | 0 | 0.03 | 0.37 | 0.04 | 0.33 | 0.09 | 0.09 | 0.26 | 0.24 | 0.37 | 0.16 | 0.18 | 0.16 | 0.31 | 0.11 | 0.14 | 0.15 | 0.18 | 0.17 | 0.30 | 0.17 | 0.20 | |||
| 138. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.26 | 0 | 0 | |||
| 139. | Subscribers only |
<1%
|
0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0.03 | 0.07 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0.06 | 0 | 0.04 | 0.08 | 0.03 | 0.03 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0.07 | 0 | 0.03 | 0 | 0 | 0 | 0.08 | 0.72 | 0.14 | 0.45 | 0.17 | 0.17 | 0.09 | 0.46 | 0.13 | 0.17 | 0.18 | 0.30 | 0.60 | 0.24 | 0.52 | 1.06 | 0.80 | 0.39 | |||
| 140. | Subscribers only |
<1%
|
0.16 | 0.33 | 0 | 0.09 | 0 | 0 | 0.04 | 0.05 | 0 | 0 | 0 | 0 | 0.07 | 0 | 0 | 0 | 0.14 | 0 | 0.16 | 0 | 0.06 | 0.03 | 0 | 0.21 | 0 | 0 | 0 | 0.16 | 0.40 | 1.79 | 0.03 | 0 | 0.91 | 0.20 | 0.28 | 0.43 | 0.04 | 0.16 | 0.14 | 0.18 | 0 | 0.06 | 0 | 0.33 | 0 | 0 | 0.07 | 0.21 | 0.04 | 0 | 0 | 0.06 | |||
| 141. | Subscribers only |
<1%
|
0.04 | 0.21 | 0.09 | 0 | 0.09 | 0 | 0.10 | 0 | 0.10 | 0 | 0 | 0.15 | 0.06 | 0.07 | 0.08 | 0.16 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0.03 | 0.21 | 0.79 | 0.04 | 0.73 | 0.08 | 0.09 | 0.08 | 0 | 0 | 1.21 | 0.49 | 0.03 | 0.05 | 0.07 | 0 | 0.07 | 0.03 | 1.09 | 0 | 0.12 | 0.04 | 0.09 | 0.10 | 0.03 | 0 | 0.03 | 0.07 | 0 | 0.03 | |||
| 142. | Subscribers only |
<1%
|
0.05 | 0.16 | 0.30 | 0 | 0.07 | 0.07 | 0.07 | 0.14 | 0.14 | 0.11 | 0.04 | 0.07 | 0.07 | 0.13 | 0.13 | 0.06 | 0.03 | 0.07 | 0.03 | 0.10 | 0 | 0.16 | 0.31 | 0.04 | 0.10 | 0.10 | 0.29 | 0.10 | 0.06 | 0.20 | 0.36 | 0.11 | 0.24 | 0 | 0.39 | 0.37 | 0.11 | 0 | 0.20 | 0.29 | 0.13 | 0.19 | 0.03 | 0.13 | 0.08 | 0.12 | 0.10 | 0 | 0.07 | 0.17 | 0.16 | 0.04 | |||
| 143. | Subscribers only |
<1%
|
0 | 0.11 | 0.06 | 1.12 | 0.03 | 0 | 0 | 0.13 | 0.17 | 0.72 | 0 | 0 | 0 | 0 | 1.30 | 0 | 0.04 | 1.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0.17 | 0 | 0.03 | 0 | 0 | 0 | 0.43 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0.15 | 0.45 | 0 | 0.21 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | |||
| 144. | Gibraltar |
<1%
|
0 | 0 | 2.75 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0.05 | 0 | 0.06 | 1.66 | 0 | 0.06 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.24 | 0.25 | 0.22 | 0.37 | 0.12 | 0.03 | |||
| 145. | Subscribers only |
<1%
|
0 | 0 | 0 | 0.08 | 0 | 0 | 0.25 | 0 | 0.15 | 0 | 0 | 0 | 0 | 0 | 0 | 0.18 | 0 | 0 | 0 | 0.38 | 0.05 | 0 | 0 | 0.03 | 0 | 0.06 | 0 | 0.07 | 0.11 | 0 | 0 | 0 | 0 | 0.07 | 0.49 | 0.08 | 0 | 0.06 | 0.08 | 0.08 | 0.41 | 0.39 | 0.27 | 0.24 | 0.97 | 0 | 0.31 | 0.16 | 0.05 | 0.39 | 0.04 | 0.05 | |||
| 146. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0.07 | 0.19 | 0 | 3.25 | 1.61 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 147. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.74 | 0 | 0.07 | 0 | 0 | 0 | 0.11 | 0 | 0.08 | 0 | 1.12 | 0 | 0.09 | 0 | 0.49 | 0 | 0.60 | 0 | 0 | 0 | 0 | 0.23 | 0 | 1.35 | 0 | |||
| 148. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.26 | 0 | 0.03 | 1.14 | 0 | 0 | 0 | 2.25 | 0 | 0.56 | 0 | 0.04 | 0 | 0.47 | 0 | 0.14 | |||
| 149. | Subscribers only |
<1%
|
0 | 0 | 0.11 | 0 | 0.23 | 0.04 | 0 | 0 | 0.10 | 0.05 | 0 | 0.08 | 0 | 0.06 | 0 | 0 | 0.15 | 0.05 | 0.09 | 0 | 0.40 | 0 | 0.09 | 0.21 | 0.06 | 0 | 0.03 | 0 | 0.11 | 0 | 0.63 | 0.12 | 0 | 0.04 | 0 | 0 | 0.04 | 0.05 | 0.03 | 0.08 | 0.11 | 0.09 | 0.04 | 0 | 0.03 | 0.11 | 0.47 | 0 | 0.07 | 0.03 | 0.20 | 0.10 | |||
| 150. | Subscribers only |
<1%
|
0.11 | 0 | 0 | 0 | 0 | 0 | 0.14 | 0 | 0 | 0 | 0 | 0.08 | 0 | 0 | 0 | 0.05 | 0.07 | 0 | 0.07 | 0 | 0.13 | 0.07 | 0 | 0 | 0.10 | 0.05 | 0.10 | 0 | 0 | 0 | 0 | 0 | 0.10 | 0 | 0.21 | 0.18 | 0.24 | 0.19 | 0 | 0.24 | 0 | 0.25 | 0.49 | 0 | 0 | 0.08 | 0.03 | 0 | 0 | 0 | 0.08 | 0.10 | |||
| 151. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0.57 | 0 | 0 | 0.54 | 0 | 0 | 0 | 0.36 | 0 | 0 | 0.03 | 0 | 0.58 | 0.43 | 0.11 | 0.05 | 0 | 0 | 0.04 | 0 | 0.04 | 0 | 0.08 | 0 | 0 | 0 | 0 | 0.03 | 0.06 | 0 | 0 | 0 | |||
| 152. | Subscribers only |
<1%
|
0 | 0 | 0 | 0.23 | 0 | 0 | 0 | 0 | 0.03 | 0.57 | 0 | 0 | 0 | 0.21 | 0 | 0 | 0.23 | 0 | 1.06 | 0 | 0 | 0 | 0 | 0.07 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.06 | 0.06 | 0 | 0.03 | 0 | 0 | 0.06 | 0 | 0.07 | |||
| 153. | Subscribers only |
<1%
|
0.22 | 0 | 0.32 | 0.16 | 0.45 | 0.31 | 0 | 0.09 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0.08 | 0.27 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0.15 | 0 | 0.10 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0.22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | |||
| 154. | Subscribers only |
<1%
|
2.35 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 155. | Subscribers only |
<1%
|
0 | 0.21 | 0 | 0.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.30 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.19 | 0 | 0 | 0 | 0 | 0 | 0 | 0.11 | 0 | 0 | 0 | 0 | 0.54 | 0 | 0.50 | 0 | 0.06 | 0 | 0 | 0 | 0.06 | 0 | 0 | 0 | |||
| 156. | Subscribers only |
<1%
|
0.19 | 0 | 0.13 | 0 | 0 | 0.09 | 0 | 0 | 0.18 | 0 | 0.05 | 0.07 | 0.03 | 0 | 0.21 | 0.16 | 0.35 | 0 | 0 | 0 | 0.12 | 0 | 0 | 0 | 0.09 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0.12 | 0.05 | 0 | 0 | 0 | 0 | 0.26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0 | |||
| 157. | Subscribers only |
<1%
|
0 | 0 | 1.91 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 158. | Subscribers only |
<1%
|
0 | 0 | 0.04 | 0.18 | 0 | 0 | 0.10 | 0.18 | 0.06 | 0 | 0.25 | 0 | 0.23 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.06 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0.18 | 0 | 0 | 0 | 0.31 | 0 | 0 | 0.03 | 0 | 0.15 | 0 | 0 | 0 | 0 | 0 | |||
| 159. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.07 | 1.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0.35 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 160. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0.09 | 0.03 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 1.35 | 0.04 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0.06 | 0 | 0.03 | 0 | 0 | 0 | |||
| 161. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0.11 | 0 | 0 | 0.04 | 0.27 | 0 | 0 | 0.20 | 0.09 | 0.08 | 0.31 | 0.06 | 0.06 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0.03 | 0.11 | 0 | 0.03 | 0 | 0.10 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0.09 | 0 | |||
| 162. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.72 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.72 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 163. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0.09 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.61 | 0 | 0 | 0 | 0.16 | 0.04 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.57 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | |||
| 164. | Subscribers only |
<1%
|
0 | 0 | 0.97 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.55 | 0 | |||
| 165. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.31 | 0 | 0 | 0 | 0.38 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0.05 | 0.04 | 0 | 0 | 0 | 0 | 0.07 | 0 | 0 | 0 | 0 | 0 | 0 | 0.06 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | |||
| 166. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0.96 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 167. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0.03 | 0.03 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0.06 | 0 | 0 | 0.03 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0.06 | 0 | 0.04 | 0 | 0.12 | 0.12 | 0 | 0.09 | 0 | 0 | 0 | 0 | 0 | 0 | 0.06 | 0 | 0 | 0.09 | 0 | 0 | 0 | 0.08 | 0 | 0 | 0 | 0.04 | 0 | 0.06 | |||
| 168. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.09 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.62 | 0 | 0 | 0 | 0 | 0 | 0.12 | 0 | 0 | 0 | 0 | 0 | |||
| 169. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0.34 | 0 | 0 | 0 | 0 | 0 | 0 | 0.45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 170. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0.03 | 0.29 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0.03 | 0 | 0.05 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0.11 | 0 | 0 | 0 | 0.07 | 0 | 0 | 0 | |||
| 171. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0.06 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0.16 | 0.04 | 0.10 | 0 | 0.07 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 172. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0.11 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0.17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.22 | 0 | 0 | |||
| 173. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.15 | 0 | 0 | 0 | 0.33 | 0 | |||
| 174. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.54 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 175. | Subscribers only |
<1%
|
0 | 0.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0.13 | 0 | 0 | |||
| 176. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.36 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | |||
| 177. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.47 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 178. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0.42 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 179. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.06 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.14 | 0 | 0 | 0 | 0.06 | 0 | 0 | 0 | 0 | 0 | 0.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 180. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 181. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 182. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.07 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0.03 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0.09 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0 | |||
| 183. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0.10 | 0 | 0 | 0 | 0 | 0 | 0.14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 184. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.27 | 0 | 0 | 0 | |||
| 185. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 186. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.16 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 187. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0.14 | 0 | 0 | 0 | 0 | |||
| 188. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.19 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 189. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.06 | 0 | 0 | 0.13 | 0 | |||
| 190. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.06 | 0 | 0 | 0 | 0 | 0 | 0 | 0.09 | 0 | 0 | 0 | 0 | 0.04 | |||
| 191. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0.05 | 0 | 0 | 0 | 0 | 0 | |||
| 192. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.11 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 193. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 194. | Subscribers only |
<1%
|
0 | 0 | 0 | 0.06 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | |||
| 195. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 196. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.06 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 197. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 198. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 199. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 200. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 201. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 |
| Import | Export | Description |
|---|---|---|
| 30 | 30 | Pharmaceutical products |
| 3001 | 3001 | Pharmaceutical products: Glands and other organs for organotherapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organotherapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included: |
| 3002 | 3002 | Pharmaceutical products: Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: |
| 3003 | 3003 | Pharmaceutical products: Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale: |
| 3004 | 3004 | Pharmaceutical products: Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: |
| 3004.10 | 3004.10 | Pharmaceutical products: Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives: |
| 3004.20 | 3004.20 | Medicaments containing other antibiotics (excl. of 3004.10), put up in measured doses/forms/packings for RS |
| 3004.31 | 3004.31 | Medicaments containing insulin, put up in measured doses/forms/packings for RS |
| 3004.32 | 3004.32 | Medicaments containing corticosteroid hormones, their derivatives & structural analogues, put up in measured doses/forms/packings for RS |
| 3004.39 | 3004.39 | Medicaments containing hormones/other products of 29.37 but not containing antibiotics, put up in measured doses/forms/packings for RS |
| 3004.40 | 3004.40 | Medicaments containing alkaloids/derivatives thereof but not containing hormones/other products of 29.37/antibiotics, put up in measured doses/forms/packings for RS |
| 3004.50 | 3004.50 | Pharmaceutical products: Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other medicaments containing vitamins or other products of heading 2936: |
| 3004.90 | 3004.90 | Pharmaceutical products: Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: |
| 3005 | 3005 | Pharmaceutical products: Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes: |
| 3006 | 3006 | Pharmaceutical products: Pharmaceutical goods specified in note 4 to this chapter: |